trees,first_mesh,relbl
C18.654.726,Overnutrition,C18.654.726 - Overnutrition
C10.228.140.079.862,Parkinsonian Disorders,C10.228.140.079.862 - Parkinsonian Disorders
C10.228.662.600,Parkinsonian Disorders,C10.228.662.600 - Parkinsonian Disorders
G09.772,Respiratory Physiological Phenomena,G09.772 - Respiratory Physiological Phenomena
E01.370.600,Physical Examination,E01.370.600 - Physical Examination
A02,Musculoskeletal System,A02 - Musculoskeletal System
E02.095.465.425,Immunotherapy,E02.095.465.425 - Immunotherapy
D03.383.129.308,Imidazoles,D03.383.129.308 - Imidazoles
C20.543,Hypersensitivity,C20.543 - Hypersensitivity
D12.776.124.400,Hemoglobins,D12.776.124.400 - Hemoglobins
D12.776.422.316.762,Hemoglobins,D12.776.422.316.762 - Hemoglobins
C12.050.351.968.419.570.363,Glomerulonephritis,C12.050.351.968.419.570.363 - Glomerulonephritis
C12.200.777.419.570.363,Glomerulonephritis,C12.200.777.419.570.363 - Glomerulonephritis
C12.950.419.570.363,Glomerulonephritis,C12.950.419.570.363 - Glomerulonephritis
C12.050.351.968.419.780.050,Acute Kidney Injury,C12.050.351.968.419.780.050 - Acute Kidney Injury
C12.200.777.419.780.050,Acute Kidney Injury,C12.200.777.419.780.050 - Acute Kidney Injury
C12.950.419.780.050,Acute Kidney Injury,C12.950.419.780.050 - Acute Kidney Injury
C19.246.099,Diabetes Complications,C19.246.099 - Diabetes Complications
C23.300,"Pathological Conditions, Anatomical","C23.300 - Pathological Conditions, Anatomical"
D03.383.129.578,Pyrroles,D03.383.129.578 - Pyrroles
E01.789.625,Neoplasm Staging,E01.789.625 - Neoplasm Staging
G11.427,Musculoskeletal Physiological Phenomena,G11.427 - Musculoskeletal Physiological Phenomena
C10.114.375.500,Multiple Sclerosis,C10.114.375.500 - Multiple Sclerosis
C10.314.350.500,Multiple Sclerosis,C10.314.350.500 - Multiple Sclerosis
C20.111.258.250.500,Multiple Sclerosis,C20.111.258.250.500 - Multiple Sclerosis
D12.644.276.374.465,Interleukins,D12.644.276.374.465 - Interleukins
D12.776.467.374.465,Interleukins,D12.776.467.374.465 - Interleukins
D23.529.374.465,Interleukins,D23.529.374.465 - Interleukins
A03,Digestive System,A03 - Digestive System
E02.148.050.060,"Angioplasty, Balloon","E02.148.050.060 - Angioplasty, Balloon"
E04.100.814.529.124.060,"Angioplasty, Balloon","E04.100.814.529.124.060 - Angioplasty, Balloon"
E04.502.382.124.060,"Angioplasty, Balloon","E04.502.382.124.060 - Angioplasty, Balloon"
E05.157.016.060,"Angioplasty, Balloon","E05.157.016.060 - Angioplasty, Balloon"
E02.319.267.082,"Administration, Intravenous","E02.319.267.082 - Administration, Intravenous"
C12.050.351.968.419.780.400,Cardio-Renal Syndrome,C12.050.351.968.419.780.400 - Cardio-Renal Syndrome
C12.200.777.419.780.400,Cardio-Renal Syndrome,C12.200.777.419.780.400 - Cardio-Renal Syndrome
C12.950.419.780.400,Cardio-Renal Syndrome,C12.950.419.780.400 - Cardio-Renal Syndrome
C14.280.434.156,Cardio-Renal Syndrome,C14.280.434.156 - Cardio-Renal Syndrome
E02.095.465,Immunomodulation,E02.095.465 - Immunomodulation
G12.535,Immunomodulation,G12.535 - Immunomodulation
D03.383.129.617,Tetrazoles,D03.383.129.617 - Tetrazoles
C18.452.394.750.774,Prediabetic State,C18.452.394.750.774 - Prediabetic State
C19.246.774,Prediabetic State,C19.246.774 - Prediabetic State
C23.550,Pathologic Processes,C23.550 - Pathologic Processes
C10.228.140.079.862.500,Parkinson Disease,C10.228.140.079.862.500 - Parkinson Disease
C10.228.662.600.400,Parkinson Disease,C10.228.662.600.400 - Parkinson Disease
C10.574.928.750,Parkinson Disease,C10.574.928.750 - Parkinson Disease
G11.561,Nervous System Physiological Phenomena,G11.561 - Nervous System Physiological Phenomena
A07,Cardiovascular System,A07 - Cardiovascular System
D08.811.520.650.600.750,Soluble Guanylyl Cyclase,D08.811.520.650.600.750 - Soluble Guanylyl Cyclase
D12.776.476.350.500,Soluble Guanylyl Cyclase,D12.776.476.350.500 - Soluble Guanylyl Cyclase
A18,Plant Structures,A18 - Plant Structures
E02.148.050,Angioplasty,E02.148.050 - Angioplasty
E04.100.814.529.124,Angioplasty,E04.100.814.529.124 - Angioplasty
E04.502.382.124,Angioplasty,E04.502.382.124 - Angioplasty
E05.157.016,Angioplasty,E05.157.016 - Angioplasty
D02.886.675,Thiazoles,D02.886.675 - Thiazoles
D03.383.129.708,Thiazoles,D03.383.129.708 - Thiazoles
C23.888,Signs and Symptoms,C23.888 - Signs and Symptoms
H02.403,Medicine,H02.403 - Medicine
E02.319.267.510,"Infusions, Parenteral","E02.319.267.510 - Infusions, Parenteral"
C05.550.114.122,"Arthritis, Juvenile","C05.550.114.122 - Arthritis, Juvenile"
C05.799.056,"Arthritis, Juvenile","C05.799.056 - Arthritis, Juvenile"
C17.300.775.049,"Arthritis, Juvenile","C17.300.775.049 - Arthritis, Juvenile"
C20.111.198,"Arthritis, Juvenile","C20.111.198 - Arthritis, Juvenile"
D10.532.091.200,Apolipoproteins A,D10.532.091.200 - Apolipoproteins A
D12.776.070.400.200,Apolipoproteins A,D12.776.070.400.200 - Apolipoproteins A
D12.776.521.120.200,Apolipoproteins A,D12.776.521.120.200 - Apolipoproteins A
C10.228.140.380.100,Alzheimer Disease,C10.228.140.380.100 - Alzheimer Disease
C10.574.945.249,Alzheimer Disease,C10.574.945.249 - Alzheimer Disease
F03.615.400.100,Alzheimer Disease,F03.615.400.100 - Alzheimer Disease
C12.050.351.968.934.734.269,Albuminuria,C12.050.351.968.934.734.269 - Albuminuria
C12.200.777.934.734.269,Albuminuria,C12.200.777.934.734.269 - Albuminuria
C12.950.934.734.269,Albuminuria,C12.950.934.734.269 - Albuminuria
C23.888.942.750.269,Albuminuria,C23.888.942.750.269 - Albuminuria
C26.404,"Fractures, Bone","C26.404 - Fractures, Bone"
E02.319.452.150,Estrogen Replacement Therapy,E02.319.452.150 - Estrogen Replacement Therapy
D12.776.624.664.520,"Oncogene Proteins, Viral","D12.776.624.664.520 - Oncogene Proteins, Viral"
D12.776.964.700,"Oncogene Proteins, Viral","D12.776.964.700 - Oncogene Proteins, Viral"
E02.319.267,Drug Administration Routes,E02.319.267 - Drug Administration Routes
I01.240,Demography,I01.240 - Demography
N01.224,Demography,N01.224 - Demography
N06.850.505.400,Demography,N06.850.505.400 - Demography
C10.597.606.150,Communication Disorders,C10.597.606.150 - Communication Disorders
C23.888.592.604.150,Communication Disorders,C23.888.592.604.150 - Communication Disorders
F03.625.374,Communication Disorders,F03.625.374 - Communication Disorders
B03,Bacteria,B03 - Bacteria
C05.550.114.154,"Arthritis, Rheumatoid","C05.550.114.154 - Arthritis, Rheumatoid"
C05.799.114,"Arthritis, Rheumatoid","C05.799.114 - Arthritis, Rheumatoid"
C17.300.775.099,"Arthritis, Rheumatoid","C17.300.775.099 - Arthritis, Rheumatoid"
C20.111.199,"Arthritis, Rheumatoid","C20.111.199 - Arthritis, Rheumatoid"
D02.065.884.675,Sildenafil Citrate,D02.065.884.675 - Sildenafil Citrate
D02.886.590.700.675,Sildenafil Citrate,D02.886.590.700.675 - Sildenafil Citrate
D03.383.606.854,Sildenafil Citrate,D03.383.606.854 - Sildenafil Citrate
D03.633.100.759.824,Sildenafil Citrate,D03.633.100.759.824 - Sildenafil Citrate
C26.411,"Fractures, Cartilage","C26.411 - Fractures, Cartilage"
C10.114,Autoimmune Diseases of the Nervous System,C10.114 - Autoimmune Diseases of the Nervous System
C20.111.258,Autoimmune Diseases of the Nervous System,C20.111.258 - Autoimmune Diseases of the Nervous System
E02.319.452,Hormone Replacement Therapy,E02.319.452 - Hormone Replacement Therapy
D06.472.699.631.692.781,Vasopressins,D06.472.699.631.692.781 - Vasopressins
D12.644.400.900,Vasopressins,D12.644.400.900 - Vasopressins
D12.644.456.925,Vasopressins,D12.644.456.925 - Vasopressins
D12.644.548.691.692.781,Vasopressins,D12.644.548.691.692.781 - Vasopressins
D12.776.631.650.937,Vasopressins,D12.776.631.650.937 - Vasopressins
I01.800,Quality of Life,I01.800 - Quality of Life
K01.752.400.750,Quality of Life,K01.752.400.750 - Quality of Life
N06.850.505.400.425.837,Quality of Life,N06.850.505.400.425.837 - Quality of Life
E02.760.400.600,Patient Admission,E02.760.400.600 - Patient Admission
N02.421.585.400.600,Patient Admission,N02.421.585.400.600 - Patient Admission
C01,Infections,C01 - Infections
C14.240.400.560.375,"Heart Septal Defects, Atrial","C14.240.400.560.375 - Heart Septal Defects, Atrial"
C14.280.400.560.375,"Heart Septal Defects, Atrial","C14.280.400.560.375 - Heart Septal Defects, Atrial"
C16.131.240.400.560.375,"Heart Septal Defects, Atrial","C16.131.240.400.560.375 - Heart Septal Defects, Atrial"
C10.597.606.358,Consciousness Disorders,C10.597.606.358 - Consciousness Disorders
C23.888.592.604.359,Consciousness Disorders,C23.888.592.604.359 - Consciousness Disorders
F01.700.315,Consciousness Disorders,F01.700.315 - Consciousness Disorders
F03.615.300,Consciousness Disorders,F03.615.300 - Consciousness Disorders
D03.383.663.283,Benzopyrans,D03.383.663.283 - Benzopyrans
D03.633.100.150,Benzopyrans,D03.633.100.150 - Benzopyrans
G11.427.410.698.277,Exercise,G11.427.410.698.277 - Exercise
I03.350,Exercise,I03.350 - Exercise
E02.774.945.500,PUVA Therapy,E02.774.945.500 - PUVA Therapy
D08.622.509,Pepsinogens,D08.622.509 - Pepsinogens
D12.776.811.243.509,Pepsinogens,D12.776.811.243.509 - Pepsinogens
C04,Neoplasms,C04 - Neoplasms
C11.768.585.439,Macular Degeneration,C11.768.585.439 - Macular Degeneration
C17.300.480,"Lupus Erythematosus, Systemic","C17.300.480 - Lupus Erythematosus, Systemic"
C20.111.590,"Lupus Erythematosus, Systemic","C20.111.590 - Lupus Erythematosus, Systemic"
E02.760.106,Ambulatory Care,E02.760.106 - Ambulatory Care
N02.421.585.106,Ambulatory Care,N02.421.585.106 - Ambulatory Care
D03.383.725.192,Dabigatran,D03.383.725.192 - Dabigatran
D03.633.100.103.280,Dabigatran,D03.633.100.103.280 - Dabigatran
D000317,Adrenergic alpha-Antagonists,D000317 - Adrenergic alpha-Antagonists
C14.280.647.187.362,"Angina, Stable","C14.280.647.187.362 - Angina, Stable"
C14.907.585.187.362,"Angina, Stable","C14.907.585.187.362 - Angina, Stable"
C23.888.592.612.233.500.575,"Angina, Stable","C23.888.592.612.233.500.575 - Angina, Stable"
C12.050.351.968,Urologic Diseases,C12.050.351.968 - Urologic Diseases
C12.200.777,Urologic Diseases,C12.200.777 - Urologic Diseases
C12.950,Urologic Diseases,C12.950 - Urologic Diseases
D03.066.515,Nicotinic Acids,D03.066.515 - Nicotinic Acids
D03.383.725.547,Nicotinic Acids,D03.383.725.547 - Nicotinic Acids
C05,Musculoskeletal Diseases,C05 - Musculoskeletal Diseases
C20.543.480,"Hypersensitivity, Immediate","C20.543.480 - Hypersensitivity, Immediate"
G07.203.300,Food,G07.203.300 - Food
J02.500,Food,J02.500 - Food
D12.776.124.270.300,Fibrin Fibrinogen Degradation Products,D12.776.124.270.300 - Fibrin Fibrinogen Degradation Products
D12.776.811.300.290,Fibrin Fibrinogen Degradation Products,D12.776.811.300.290 - Fibrin Fibrinogen Degradation Products
E03.155.086.131,"Anesthesia, Epidural","E03.155.086.131 - Anesthesia, Epidural"
E02.760.287,Duration of Therapy,E02.760.287 - Duration of Therapy
N02.421.585.287,Duration of Therapy,N02.421.585.287 - Duration of Therapy
D000319,Adrenergic beta-Antagonists,D000319 - Adrenergic beta-Antagonists
D02.886.778.823,Thienopyridines,D02.886.778.823 - Thienopyridines
D03.383.725.849,Thienopyridines,D03.383.725.849 - Thienopyridines
D03.383.903.830,Thienopyridines,D03.383.903.830 - Thienopyridines
D03.633.100.928,Thienopyridines,D03.633.100.928 - Thienopyridines
E04.100.376.485,Heart Valve Prosthesis Implantation,E04.100.376.485 - Heart Valve Prosthesis Implantation
E04.650.410,Heart Valve Prosthesis Implantation,E04.650.410 - Heart Valve Prosthesis Implantation
E04.928.220.410,Heart Valve Prosthesis Implantation,E04.928.220.410 - Heart Valve Prosthesis Implantation
C12.100.500.214,Erectile Dysfunction,C12.100.500.214 - Erectile Dysfunction
C12.100.875.486,Erectile Dysfunction,C12.100.875.486 - Erectile Dysfunction
C12.200.294.214,Erectile Dysfunction,C12.200.294.214 - Erectile Dysfunction
F03.835.400,Erectile Dysfunction,F03.835.400 - Erectile Dysfunction
E02.760.400,Hospitalization,E02.760.400 - Hospitalization
N02.421.585.400,Hospitalization,N02.421.585.400 - Hospitalization
K01.400,History,K01.400 - History
C06,Digestive System Diseases,C06 - Digestive System Diseases
C14.280.647.250.260,Coronary Artery Disease,C14.280.647.250.260 - Coronary Artery Disease
C14.907.137.126.339,Coronary Artery Disease,C14.907.137.126.339 - Coronary Artery Disease
C14.907.585.250.260,Coronary Artery Disease,C14.907.585.250.260 - Coronary Artery Disease
C23.300.287,"Constriction, Pathologic","C23.300.287 - Constriction, Pathologic"
D05.750.078.280,Collagen,D05.750.078.280 - Collagen
D12.776.860.300.250,Collagen,D12.776.860.300.250 - Collagen
D000451,Mineralocorticoid Receptor Antagonists,D000451 - Mineralocorticoid Receptor Antagonists
E02.760.928,Time-to-Treatment,E02.760.928 - Time-to-Treatment
N02.421.585.928,Time-to-Treatment,N02.421.585.928 - Time-to-Treatment
C14.280.647.250.285,Coronary Stenosis,C14.280.647.250.285 - Coronary Stenosis
C14.907.585.250.285,Coronary Stenosis,C14.907.585.250.285 - Coronary Stenosis
C12.100.500.565,Prostatic Diseases,C12.100.500.565 - Prostatic Diseases
C12.200.294.565,Prostatic Diseases,C12.200.294.565 - Prostatic Diseases
K01.752,Philosophy,K01.752 - Philosophy
E04.100.376.719,Myocardial Revascularization,E04.100.376.719 - Myocardial Revascularization
E04.928.220.520,Myocardial Revascularization,E04.928.220.520 - Myocardial Revascularization
C07,Stomatognathic Diseases,C07 - Stomatognathic Diseases
C23.300.575,Fistula,C23.300.575 - Fistula
D000700,Analgesics,D000700 - Analgesics
E04.100.814.529,Endovascular Procedures,E04.100.814.529 - Endovascular Procedures
E04.502.382,Endovascular Procedures,E04.502.382 - Endovascular Procedures
M01.686,Population Groups,M01.686 - Population Groups
N01.224.708,Population Groups,N01.224.708 - Population Groups
D12.644.276.374.465.224,Interleukin-6,D12.644.276.374.465.224 - Interleukin-6
D12.776.467.374.465.202,Interleukin-6,D12.776.467.374.465.202 - Interleukin-6
D23.529.374.465.224,Interleukin-6,D23.529.374.465.224 - Interleukin-6
E02.774.945,Ultraviolet Therapy,E02.774.945 - Ultraviolet Therapy
C14.280.647.500.750,"Shock, Cardiogenic","C14.280.647.500.750 - Shock, Cardiogenic"
C14.907.585.500.750,"Shock, Cardiogenic","C14.907.585.500.750 - Shock, Cardiogenic"
C23.550.513.355.750.750,"Shock, Cardiogenic","C23.550.513.355.750.750 - Shock, Cardiogenic"
C23.550.717.489.750.750,"Shock, Cardiogenic","C23.550.717.489.750.750 - Shock, Cardiogenic"
C23.550.835.550,"Shock, Cardiogenic","C23.550.835.550 - Shock, Cardiogenic"
C08,Respiratory Tract Diseases,C08 - Respiratory Tract Diseases
C23.300.707,Hernia,C23.300.707 - Hernia
D03.383.931.480,Lamotrigine,D03.383.931.480 - Lamotrigine
D000806,Angiotensin-Converting Enzyme Inhibitors,D000806 - Angiotensin-Converting Enzyme Inhibitors
E04.100.814.868,Vascular Grafting,E04.100.814.868 - Vascular Grafting
C09,Otorhinolaryngologic Diseases,C09 - Otorhinolaryngologic Diseases
C23.300.775,Hypertrophy,C23.300.775 - Hypertrophy
D03.633.100.079,Benzazepines,D03.633.100.079 - Benzazepines
D27.505.519.186.071,Hypolipidemic Agents,D27.505.519.186.071 - Hypolipidemic Agents
D27.505.954.557.500,Hypolipidemic Agents,D27.505.954.557.500 - Hypolipidemic Agents
E03.155.086,"Anesthesia, Conduction","E03.155.086 - Anesthesia, Conduction"
C14.280.647.500.875,ST Elevation Myocardial Infarction,C14.280.647.500.875 - ST Elevation Myocardial Infarction
C14.907.585.500.875,ST Elevation Myocardial Infarction,C14.907.585.500.875 - ST Elevation Myocardial Infarction
C23.550.513.355.750.875,ST Elevation Myocardial Infarction,C23.550.513.355.750.875 - ST Elevation Myocardial Infarction
C23.550.717.489.750.875,ST Elevation Myocardial Infarction,C23.550.717.489.750.875 - ST Elevation Myocardial Infarction
D000889,Anti-Arrhythmia Agents,D000889 - Anti-Arrhythmia Agents
C23.300.823,"Plaque, Atherosclerotic","C23.300.823 - Plaque, Atherosclerotic"
C14.907.137.126.307,Atherosclerosis,C14.907.137.126.307 - Atherosclerosis
D27.505.519.186.071.202.370,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.186.071.202.370 - Hydroxymethylglutaryl-CoA Reductase Inhibitors
D27.505.519.389.370,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.519.389.370 - Hydroxymethylglutaryl-CoA Reductase Inhibitors
D27.505.954.557.500.202.370,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D27.505.954.557.500.202.370 - Hydroxymethylglutaryl-CoA Reductase Inhibitors
I01.880.853.996,Socioeconomic Factors,I01.880.853.996 - Socioeconomic Factors
N01.824,Socioeconomic Factors,N01.824 - Socioeconomic Factors
C10,Nervous System Diseases,C10 - Nervous System Diseases
E04.100.376,Cardiac Surgical Procedures,E04.100.376 - Cardiac Surgical Procedures
E04.928.220,Cardiac Surgical Procedures,E04.928.220 - Cardiac Surgical Procedures
D03.633.100.103,Benzimidazoles,D03.633.100.103 - Benzimidazoles
D000893,Anti-Inflammatory Agents,D000893 - Anti-Inflammatory Agents
E04.100.814.529.968,Percutaneous Coronary Intervention,E04.100.814.529.968 - Percutaneous Coronary Intervention
E04.502.382.968,Percutaneous Coronary Intervention,E04.502.382.968 - Percutaneous Coronary Intervention
E04.100.700,Reperfusion,E04.100.700 - Reperfusion
E05.680.730,Reperfusion,E05.680.730 - Reperfusion
D27.505.519.389.745,Protease Inhibitors,D27.505.519.389.745 - Protease Inhibitors
C23.300.825,Polyps,C23.300.825 - Polyps
C12.050.351.968.419,Kidney Diseases,C12.050.351.968.419 - Kidney Diseases
C12.200.777.419,Kidney Diseases,C12.200.777.419 - Kidney Diseases
C12.950.419,Kidney Diseases,C12.950.419 - Kidney Diseases
N02.278,Health Facilities,N02.278 - Health Facilities
C11,Eye Diseases,C11 - Eye Diseases
D03.633.100.127,Benzofurans,D03.633.100.127 - Benzofurans
D000900,Anti-Bacterial Agents,D000900 - Anti-Bacterial Agents
D27.505.519.389.848,Proton Pump Inhibitors,D27.505.519.389.848 - Proton Pump Inhibitors
E04.100.814,Vascular Surgical Procedures,E04.100.814 - Vascular Surgical Procedures
N02.421,Health Services,N02.421 - Health Services
C12.050.351.968.829,Urinary Bladder Diseases,C12.050.351.968.829 - Urinary Bladder Diseases
C12.200.777.829,Urinary Bladder Diseases,C12.200.777.829 - Urinary Bladder Diseases
C12.950.829,Urinary Bladder Diseases,C12.950.829 - Urinary Bladder Diseases
C14.280.067,"Arrhythmias, Cardiac","C14.280.067 - Arrhythmias, Cardiac"
C23.550.073,"Arrhythmias, Cardiac","C23.550.073 - Arrhythmias, Cardiac"
C12,Urogenital Diseases,C12 - Urogenital Diseases
D000925,Anticoagulants,D000925 - Anticoagulants
C23.550.291,Disease Attributes,C23.550.291 - Disease Attributes
C12.050.351.968.934,Urination Disorders,C12.050.351.968.934 - Urination Disorders
C12.200.777.934,Urination Disorders,C12.200.777.934 - Urination Disorders
C12.950.934,Urination Disorders,C12.950.934 - Urination Disorders
N04.761,Quality of Health Care,N04.761 - Quality of Health Care
N05.715,Quality of Health Care,N05.715 - Quality of Health Care
D03.633.100.759,Purines,D03.633.100.759 - Purines
D27.505.519.421.750,Fibrinolytic Agents,D27.505.519.421.750 - Fibrinolytic Agents
D27.505.954.411.320,Fibrinolytic Agents,D27.505.954.411.320 - Fibrinolytic Agents
D27.505.954.502.427,Fibrinolytic Agents,D27.505.954.502.427 - Fibrinolytic Agents
C10.228.140.300.150.836,"Ischemic Attack, Transient","C10.228.140.300.150.836 - Ischemic Attack, Transient"
C14.907.253.092.836,"Ischemic Attack, Transient","C14.907.253.092.836 - Ischemic Attack, Transient"
E04.292.413,Cardiopulmonary Bypass,E04.292.413 - Cardiopulmonary Bypass
D000927,Anticonvulsants,D000927 - Anticonvulsants
C08.381.746,Pulmonary Embolism,C08.381.746 - Pulmonary Embolism
C14.907.355.350.700,Pulmonary Embolism,C14.907.355.350.700 - Pulmonary Embolism
H02.403.720,Public Health,H02.403.720 - Public Health
N01.400.550,Public Health,N01.400.550 - Public Health
N06.850,Public Health,N06.850 - Public Health
E01.370.388.250,Endoscopy,E01.370.388.250 - Endoscopy
E04.502.250,Endoscopy,E04.502.250 - Endoscopy
C23.550.325,Emphysema,C23.550.325 - Emphysema
E04.928.600.220,Collapse Therapy,E04.928.600.220 - Collapse Therapy
C14,Cardiovascular Diseases,C14 - Cardiovascular Diseases
D27.505.519.562.249,Calcium Channel Blockers,D27.505.519.562.249 - Calcium Channel Blockers
D27.505.696.260.500,Calcium Channel Blockers,D27.505.696.260.500 - Calcium Channel Blockers
D27.505.954.411.192,Calcium Channel Blockers,D27.505.954.411.192 - Calcium Channel Blockers
D000959,Antihypertensive Agents,D000959 - Antihypertensive Agents
C14.907.355.590.700,Venous Thromboembolism,C14.907.355.590.700 - Venous Thromboembolism
D27.505.519.625.050,Adrenergic Agents,D27.505.519.625.050 - Adrenergic Agents
D27.505.696.577.050,Adrenergic Agents,D27.505.696.577.050 - Adrenergic Agents
E01.370.600.115.100.125,Body Mass Index,E01.370.600.115.100.125 - Body Mass Index
E05.041.124.125,Body Mass Index,E05.041.124.125 - Body Mass Index
G07.100.100.125,Body Mass Index,G07.100.100.125 - Body Mass Index
N06.850.505.200.100.175,Body Mass Index,N06.850.505.200.100.175 - Body Mass Index
C15,Hemic and Lymphatic Diseases,C15 - Hemic and Lymphatic Diseases
C23.550.355,Fibrosis,C23.550.355 - Fibrosis
A02.835.232,Bone and Bones,A02.835.232 - Bone and Bones
A10.165.265,Bone and Bones,A10.165.265 - Bone and Bones
D04.210.500.054,Androstanes,D04.210.500.054 - Androstanes
D000960,Hypolipidemic Agents,D000960 - Hypolipidemic Agents
E01.370.600.115.100.160,Body Size,E01.370.600.115.100.160 - Body Size
E05.041.124.160,Body Size,E05.041.124.160 - Body Size
G07.100.100.160,Body Size,G07.100.100.160 - Body Size
G07.345.249.314,Body Size,G07.345.249.314 - Body Size
C14.907.355.830.925,Venous Thrombosis,C14.907.355.830.925 - Venous Thrombosis
D27.505.519.625.120,Cholinergic Agents,D27.505.519.625.120 - Cholinergic Agents
D27.505.696.577.120,Cholinergic Agents,D27.505.696.577.120 - Cholinergic Agents
D04.210.500.875,"Steroids, Brominated","D04.210.500.875 - Steroids, Brominated"
C16,"Congenital, Hereditary, and Neonatal Diseases and Abnormalities","C16 - Congenital, Hereditary, and Neonatal Diseases and Abnormalities"
A03.556.124,Intestines,A03.556.124 - Intestines
C12.050.351.968.419.192,Diabetic Nephropathies,C12.050.351.968.419.192 - Diabetic Nephropathies
C12.200.777.419.192,Diabetic Nephropathies,C12.200.777.419.192 - Diabetic Nephropathies
C12.950.419.192,Diabetic Nephropathies,C12.950.419.192 - Diabetic Nephropathies
C19.246.099.875,Diabetic Nephropathies,C19.246.099.875 - Diabetic Nephropathies
E04.555.080,"Amputation, Surgical","E04.555.080 - Amputation, Surgical"
C23.550.359,Frailty,C23.550.359 - Frailty
D000962,Antimalarials,D000962 - Antimalarials
A03.556.249,Lower Gastrointestinal Tract,A03.556.249 - Lower Gastrointestinal Tract
D27.505.519.625.375,Histamine Agents,D27.505.519.625.375 - Histamine Agents
D27.505.696.577.375,Histamine Agents,D27.505.696.577.375 - Histamine Agents
C17,Skin and Connective Tissue Diseases,C17 - Skin and Connective Tissue Diseases
C12.050.351.968.419.570,Nephritis,C12.050.351.968.419.570 - Nephritis
C12.200.777.419.570,Nephritis,C12.200.777.419.570 - Nephritis
C12.950.419.570,Nephritis,C12.950.419.570 - Nephritis
C23.550.414,Hemorrhage,C23.550.414 - Hemorrhage
D04.345.566.235,Cyclosporins,D04.345.566.235 - Cyclosporins
D12.644.641.235,Cyclosporins,D12.644.641.235 - Cyclosporins
E01.370.600.115.100.231,Body Surface Area,E01.370.600.115.100.231 - Body Surface Area
E05.041.124.231,Body Surface Area,E05.041.124.231 - Body Surface Area
G07.100.100.231,Body Surface Area,G07.100.100.231 - Body Surface Area
D000991,Antithrombins,D000991 - Antithrombins
E01.370.600.115.100.960,Waist-Hip Ratio,E01.370.600.115.100.960 - Waist-Hip Ratio
E05.041.124.946,Waist-Hip Ratio,E05.041.124.946 - Waist-Hip Ratio
G07.100.100.960,Waist-Hip Ratio,G07.100.100.960 - Waist-Hip Ratio
C23.550.449,Hyperuricemia,C23.550.449 - Hyperuricemia
C12.050.351.968.419.775,Renal Artery Obstruction,C12.050.351.968.419.775 - Renal Artery Obstruction
C12.200.777.419.775,Renal Artery Obstruction,C12.200.777.419.775 - Renal Artery Obstruction
C12.950.419.775,Renal Artery Obstruction,C12.950.419.775 - Renal Artery Obstruction
C14.907.137.727,Renal Artery Obstruction,C14.907.137.727 - Renal Artery Obstruction
C18,Nutritional and Metabolic Diseases,C18 - Nutritional and Metabolic Diseases
D02.455.426.559.847.638.400,Lovastatin,D02.455.426.559.847.638.400 - Lovastatin
D04.615.638.400,Lovastatin,D04.615.638.400 - Lovastatin
A07.015.114,Arteries,A07.015.114 - Arteries
D001993,Bronchodilator Agents,D001993 - Bronchodilator Agents
A07.015.461,Microvessels,A07.015.461 - Microvessels
C12.050.351.968.419.780,Renal Insufficiency,C12.050.351.968.419.780 - Renal Insufficiency
C12.200.777.419.780,Renal Insufficiency,C12.200.777.419.780 - Renal Insufficiency
C12.950.419.780,Renal Insufficiency,C12.950.419.780 - Renal Insufficiency
E04.928.600,Pulmonary Surgical Procedures,E04.928.600 - Pulmonary Surgical Procedures
C23.550.513,Ischemia,C23.550.513 - Ischemia
D06.347,Hormone Antagonists,D06.347 - Hormone Antagonists
D27.505.696.399.450,Hormone Antagonists,D27.505.696.399.450 - Hormone Antagonists
C19,Endocrine System Diseases,C19 - Endocrine System Diseases
D002121,Calcium Channel Blockers,D002121 - Calcium Channel Blockers
A07.015.908,Veins,A07.015.908 - Veins
C12.050.351.968.934.734,Proteinuria,C12.050.351.968.934.734 - Proteinuria
C12.200.777.934.734,Proteinuria,C12.200.777.934.734 - Proteinuria
C12.950.934.734,Proteinuria,C12.950.934.734 - Proteinuria
C23.888.942.750,Proteinuria,C23.888.942.750 - Proteinuria
C23.550.717,Necrosis,C23.550.717 - Necrosis
D05.750.078.730,Microfilament Proteins,D05.750.078.730 - Microfilament Proteins
D12.776.220.525,Microfilament Proteins,D12.776.220.525 - Microfilament Proteins
C20,Immune System Diseases,C20 - Immune System Diseases
D06.472,Hormones,D06.472 - Hormones
D27.505.696.399.472,Hormones,D27.505.696.399.472 - Hormones
E01.370.600.115.100,Body Weights and Measures,E01.370.600.115.100 - Body Weights and Measures
E05.041.124,Body Weights and Measures,E05.041.124 - Body Weights and Measures
G07.100.100,Body Weights and Measures,G07.100.100 - Body Weights and Measures
E01.370.225.124.100,Blood Chemical Analysis,E01.370.225.124.100 - Blood Chemical Analysis
E05.200.124.100,Blood Chemical Analysis,E05.200.124.100 - Blood Chemical Analysis
D002317,Cardiovascular Agents,D002317 - Cardiovascular Agents
C23,"Pathological Conditions, Signs and Symptoms","C23 - Pathological Conditions, Signs and Symptoms"
C23.550.835,Shock,C23.550.835 - Shock
D06.472.334.851,Gonadal Steroid Hormones,D06.472.334.851 - Gonadal Steroid Hormones
D27.505.696.477.656,Immunosuppressive Agents,D27.505.696.477.656 - Immunosuppressive Agents
A07.541.358,Heart Atria,A07.541.358 - Heart Atria
E01.370.225.625.115,Blood Coagulation Tests,E01.370.225.625.115 - Blood Coagulation Tests
E05.200.625.115,Blood Coagulation Tests,E05.200.625.115 - Blood Coagulation Tests
D004232,Diuretics,D004232 - Diuretics
D06.472.699.584,Natriuretic Peptides,D06.472.699.584 - Natriuretic Peptides
D12.644.548.585,Natriuretic Peptides,D12.644.548.585 - Natriuretic Peptides
A18.024.249,Flowering Tops,A18.024.249 - Flowering Tops
E01.370.225.124,Clinical Chemistry Tests,E01.370.225.124 - Clinical Chemistry Tests
E05.200.124,Clinical Chemistry Tests,E05.200.124 - Clinical Chemistry Tests
C26,Wounds and Injuries,C26 - Wounds and Injuries
C15.378.100.920.360,Vitamin K Deficiency Bleeding,C15.378.100.920.360 - Vitamin K Deficiency Bleeding
C15.378.463.841.464,Vitamin K Deficiency Bleeding,C15.378.463.841.464 - Vitamin K Deficiency Bleeding
C16.614.940,Vitamin K Deficiency Bleeding,C16.614.940 - Vitamin K Deficiency Bleeding
C18.654.422.360,Vitamin K Deficiency Bleeding,C18.654.422.360 - Vitamin K Deficiency Bleeding
C18.654.521.500.133.912.360,Vitamin K Deficiency Bleeding,C18.654.521.500.133.912.360 - Vitamin K Deficiency Bleeding
D27.505.696.560.500,Diuretics,D27.505.696.560.500 - Diuretics
C14.240.400.210,Coronary Vessel Anomalies,C14.240.400.210 - Coronary Vessel Anomalies
C14.280.400.210,Coronary Vessel Anomalies,C14.280.400.210 - Coronary Vessel Anomalies
C16.131.240.400.210,Coronary Vessel Anomalies,C16.131.240.400.210 - Coronary Vessel Anomalies
C23.888.144,Body Weight,C23.888.144 - Body Weight
E01.370.600.115.100.160.120,Body Weight,E01.370.600.115.100.160.120 - Body Weight
E01.370.600.115.450.375,Body Weight,E01.370.600.115.450.375 - Body Weight
E05.041.124.160.750,Body Weight,E05.041.124.160.750 - Body Weight
G07.100.100.160.120,Body Weight,G07.100.100.160.120 - Body Weight
G07.100.175.313,Body Weight,G07.100.175.313 - Body Weight
G07.345.249.314.120,Body Weight,G07.345.249.314.120 - Body Weight
E01.370.225.625.125,Blood Sedimentation,E01.370.225.625.125 - Blood Sedimentation
E05.200.625.125,Blood Sedimentation,E05.200.625.125 - Blood Sedimentation
D004967,Estrogens,D004967 - Estrogens
B03.440.500,Helicobacter,B03.440.500 - Helicobacter
B03.660.150.235.500.250,Helicobacter,B03.660.150.235.500.250 - Helicobacter
D06.472.699.587,Pancreatic Hormones,D06.472.699.587 - Pancreatic Hormones
D12.644.548.586,Pancreatic Hormones,D12.644.548.586 - Pancreatic Hormones
C10.597,Neurologic Manifestations,C10.597 - Neurologic Manifestations
C23.888.592,Neurologic Manifestations,C23.888.592 - Neurologic Manifestations
E01.370.225.625,Hematologic Tests,E01.370.225.625 - Hematologic Tests
E05.200.625,Hematologic Tests,E05.200.625 - Hematologic Tests
E01.370.225.625.400,Hematocrit,E01.370.225.625.400 - Hematocrit
E05.200.625.400,Hematocrit,E05.200.625.400 - Hematocrit
G09.188.370.374,Hematocrit,G09.188.370.374 - Hematocrit
C14.240.400.560,Heart Septal Defects,C14.240.400.560 - Heart Septal Defects
C14.280.400.560,Heart Septal Defects,C14.280.400.560 - Heart Septal Defects
C16.131.240.400.560,Heart Septal Defects,C16.131.240.400.560 - Heart Septal Defects
D005343,Fibrinolytic Agents,D005343 - Fibrinolytic Agents
B03.660.150,Epsilonproteobacteria,B03.660.150 - Epsilonproteobacteria
C15.378.553.231.549,Hypereosinophilic Syndrome,C15.378.553.231.549 - Hypereosinophilic Syndrome
E05.318.740,Statistics as Topic,E05.318.740 - Statistics as Topic
H01.548.832,Statistics as Topic,H01.548.832 - Statistics as Topic
N05.715.360.750,Statistics as Topic,N05.715.360.750 - Statistics as Topic
N06.850.520.830,Statistics as Topic,N06.850.520.830 - Statistics as Topic
E05.318.740.600,Probability,E05.318.740.600 - Probability
G17.680,Probability,G17.680 - Probability
N05.715.360.750.625,Probability,N05.715.360.750.625 - Probability
N06.850.520.830.600,Probability,N06.850.520.830.600 - Probability
D06.472.699.631,Pituitary Hormones,D06.472.699.631 - Pituitary Hormones
D12.644.548.691,Pituitary Hormones,D12.644.548.691 - Pituitary Hormones
C07.465.634,Oral Manifestations,C07.465.634 - Oral Manifestations
C23.888.619,Oral Manifestations,C23.888.619 - Oral Manifestations
D01,Inorganic Chemicals,D01 - Inorganic Chemicals
C14.280.067.198,Atrial Fibrillation,C14.280.067.198 - Atrial Fibrillation
C23.550.073.198,Atrial Fibrillation,C23.550.073.198 - Atrial Fibrillation
D005765,Gastrointestinal Agents,D005765 - Gastrointestinal Agents
E07.305.250.159,Defibrillators,E07.305.250.159 - Defibrillators
C14.280.195.400,"Hypertrophy, Left Ventricular","C14.280.195.400 - Hypertrophy, Left Ventricular"
C23.300.775.250.400,"Hypertrophy, Left Ventricular","C23.300.775.250.400 - Hypertrophy, Left Ventricular"
C01.160.762,Spondylitis,C01.160.762 - Spondylitis
C05.116.165.762,Spondylitis,C05.116.165.762 - Spondylitis
C05.116.900.853,Spondylitis,C05.116.900.853 - Spondylitis
C23.888.821,"Signs and Symptoms, Digestive","C23.888.821 - Signs and Symptoms, Digestive"
D08.811.277.656,Peptide Hydrolases,D08.811.277.656 - Peptide Hydrolases
D02,Organic Chemicals,D02 - Organic Chemicals
D006633,Histamine Antagonists,D006633 - Histamine Antagonists
D08.811.520.650,Phosphorus-Oxygen Lyases,D08.811.520.650 - Phosphorus-Oxygen Lyases
C14.280.383.220,"Death, Sudden, Cardiac","C14.280.383.220 - Death, Sudden, Cardiac"
C23.550.260.322.250,"Death, Sudden, Cardiac","C23.550.260.322.250 - Death, Sudden, Cardiac"
C23.888.852,"Signs and Symptoms, Respiratory","C23.888.852 - Signs and Symptoms, Respiratory"
D03,Heterocyclic Compounds,D03 - Heterocyclic Compounds
E07.305.250.319,"Electrodes, Implanted","E07.305.250.319 - Electrodes, Implanted"
E07.695.202,"Electrodes, Implanted","E07.695.202 - Electrodes, Implanted"
E07.305.250,Electrodes,E07.305.250 - Electrodes
C01.748.099,Bronchitis,C01.748.099 - Bronchitis
C08.127.446,Bronchitis,C08.127.446 - Bronchitis
C08.381.495.146,Bronchitis,C08.381.495.146 - Bronchitis
C08.730.099,Bronchitis,C08.730.099 - Bronchitis
D27.505.696.663.050,Autonomic Agents,D27.505.696.663.050 - Autonomic Agents
D007004,Hypoglycemic Agents,D007004 - Hypoglycemic Agents
D27.505.696.663.850,Sensory System Agents,D27.505.696.663.850 - Sensory System Agents
E07.305.250.159.175,"Defibrillators, Implantable","E07.305.250.159.175 - Defibrillators, Implantable"
E07.305.250.319.175,"Defibrillators, Implantable","E07.305.250.319.175 - Defibrillators, Implantable"
E07.695.202.175,"Defibrillators, Implantable","E07.695.202.175 - Defibrillators, Implantable"
C05.116.900.853.625.800.424,"Arthritis, Psoriatic","C05.116.900.853.625.800.424 - Arthritis, Psoriatic"
C05.550.114.145,"Arthritis, Psoriatic","C05.550.114.145 - Arthritis, Psoriatic"
C05.550.114.865.800.424,"Arthritis, Psoriatic","C05.550.114.865.800.424 - Arthritis, Psoriatic"
C17.800.859.675.175,"Arthritis, Psoriatic","C17.800.859.675.175 - Arthritis, Psoriatic"
C23.888.885,Skin Manifestations,C23.888.885 - Skin Manifestations
D04,Polycyclic Compounds,D04 - Polycyclic Compounds
C01.748.610,Pneumonia,C01.748.610 - Pneumonia
C08.381.677,Pneumonia,C08.381.677 - Pneumonia
C08.730.610,Pneumonia,C08.730.610 - Pneumonia
D08.811.913.696,Phosphotransferases,D08.811.913.696 - Phosphotransferases
D007166,Immunosuppressive Agents,D007166 - Immunosuppressive Agents
E07.695.750.500,Drug-Eluting Stents,E07.695.750.500 - Drug-Eluting Stents
D05,Macromolecular Substances,D05 - Macromolecular Substances
C23.888.942,Urological Manifestations,C23.888.942 - Urological Manifestations
E07.695.310,Heart Valve Prosthesis,E07.695.310 - Heart Valve Prosthesis
C01.160,"Bone Diseases, Infectious","C01.160 - Bone Diseases, Infectious"
C05.116.165,"Bone Diseases, Infectious","C05.116.165 - Bone Diseases, Infectious"
D27.505.954.122.085,Anti-Bacterial Agents,D27.505.954.122.085 - Anti-Bacterial Agents
C14.907.079,Angioedema,C14.907.079 - Angioedema
C17.800.862.945.066,Angioedema,C17.800.862.945.066 - Angioedema
C20.543.480.904.066,Angioedema,C20.543.480.904.066 - Angioedema
E07.695.750,Stents,E07.695.750 - Stents
D06,"Hormones, Hormone Substitutes, and Hormone Antagonists","D06 - Hormones, Hormone Substitutes, and Hormone Antagonists"
D27.505.696.399,"Hormones, Hormone Substitutes, and Hormone Antagonists","D27.505.696.399 - Hormones, Hormone Substitutes, and Hormone Antagonists"
D09.698.373.400,Heparin,D09.698.373.400 - Heparin
D01.268,Elements,D01.268 - Elements
C18.452.394.750.124,"Diabetes Mellitus, Type 1","C18.452.394.750.124 - Diabetes Mellitus, Type 1"
C19.246.267,"Diabetes Mellitus, Type 1","C19.246.267 - Diabetes Mellitus, Type 1"
C20.111.327,"Diabetes Mellitus, Type 1","C20.111.327 - Diabetes Mellitus, Type 1"
F01.145.126.350,Depression,F01.145.126.350 - Depression
F01.470.282,Depression,F01.470.282 - Depression
C05.116.198,"Bone Diseases, Metabolic","C05.116.198 - Bone Diseases, Metabolic"
C18.452.104,"Bone Diseases, Metabolic","C18.452.104 - Bone Diseases, Metabolic"
D27.505.954.122.250,Antiparasitic Agents,D27.505.954.122.250 - Antiparasitic Agents
D000079424,Tumor Necrosis Factor Inhibitors,D000079424 - Tumor Necrosis Factor Inhibitors
C14.280.647.124,Acute Coronary Syndrome,C14.280.647.124 - Acute Coronary Syndrome
C14.907.585.124,Acute Coronary Syndrome,C14.907.585.124 - Acute Coronary Syndrome
D08,Enzymes and Coenzymes,D08 - Enzymes and Coenzymes
C05.116.540,Hyperostosis,C05.116.540 - Hyperostosis
D01.268.549,"Metals, Alkali","D01.268.549 - Metals, Alkali"
D01.552.528,"Metals, Alkali","D01.552.528 - Metals, Alkali"
D01.552,Metals,D01.552 - Metals
D09.947.875.359,Hexoses,D09.947.875.359 - Hexoses
C18.452.394.750.149,"Diabetes Mellitus, Type 2","C18.452.394.750.149 - Diabetes Mellitus, Type 2"
C19.246.300,"Diabetes Mellitus, Type 2","C19.246.300 - Diabetes Mellitus, Type 2"
F01.145.126,Behavioral Symptoms,F01.145.126 - Behavioral Symptoms
F01.145.317.269,Alcohol Drinking,F01.145.317.269 - Alcohol Drinking
D27.505.954.158.757,Tumor Necrosis Factor Inhibitors,D27.505.954.158.757 - Tumor Necrosis Factor Inhibitors
D010975,Platelet Aggregation Inhibitors,D010975 - Platelet Aggregation Inhibitors
D01.268.557,"Metals, Light","D01.268.557 - Metals, Light"
D01.552.547,"Metals, Light","D01.552.547 - Metals, Light"
C05.116.680,Osteitis,C05.116.680 - Osteitis
D09.947.875.465,Ketoses,D09.947.875.465 - Ketoses
F01.145.317,Drinking Behavior,F01.145.317 - Drinking Behavior
D09,Carbohydrates,D09 - Carbohydrates
D27.505.954.411.097,Anti-Arrhythmia Agents,D27.505.954.411.097 - Anti-Arrhythmia Agents
C14.280.647.187,Angina Pectoris,C14.280.647.187 - Angina Pectoris
C14.907.585.187,Angina Pectoris,C14.907.585.187 - Angina Pectoris
C23.888.592.612.233.500,Angina Pectoris,C23.888.592.612.233.500 - Angina Pectoris
F01.145.805.063,Pipe Smoking,F01.145.805.063 - Pipe Smoking
D014665,Vasodilator Agents,D014665 - Vasodilator Agents
C18.452.394.952.500,Glucose Intolerance,C18.452.394.952.500 - Glucose Intolerance
C05.116.900,Spinal Diseases,C05.116.900 - Spinal Diseases
F01.145.805,Smoking,F01.145.805 - Smoking
D01.268.558,"Metals, Rare Earth","D01.268.558 - Metals, Rare Earth"
D01.552.550,"Metals, Rare Earth","D01.552.550 - Metals, Rare Earth"
D10,Lipids,D10 - Lipids
D10.212.302.380,"Dietary Fats, Unsaturated","D10.212.302.380 - Dietary Fats, Unsaturated"
G07.203.300.375.400,"Dietary Fats, Unsaturated","G07.203.300.375.400 - Dietary Fats, Unsaturated"
J02.500.375.400,"Dietary Fats, Unsaturated","J02.500.375.400 - Dietary Fats, Unsaturated"
C14.280.647.250,Coronary Disease,C14.280.647.250 - Coronary Disease
C14.907.585.250,Coronary Disease,C14.907.585.250 - Coronary Disease
D27.505.954.411.162,Antihypertensive Agents,D27.505.954.411.162 - Antihypertensive Agents
F01.145.805.375,Tobacco Smoking,F01.145.805.375 - Tobacco Smoking
F01.145.958.875,Tobacco Smoking,F01.145.958.875 - Tobacco Smoking
D018501,Antirheumatic Agents,D018501 - Antirheumatic Agents
F01.145.958,Tobacco Use,F01.145.958 - Tobacco Use
D10.212.302.380.410,"Fatty Acids, Omega-3","D10.212.302.380.410 - Fatty Acids, Omega-3"
D10.251.355.337,"Fatty Acids, Omega-3","D10.251.355.337 - Fatty Acids, Omega-3"
D10.627.430.450,"Fatty Acids, Omega-3","D10.627.430.450 - Fatty Acids, Omega-3"
C14.280.647.500,Myocardial Infarction,C14.280.647.500 - Myocardial Infarction
C14.907.585.500,Myocardial Infarction,C14.907.585.500 - Myocardial Infarction
C23.550.513.355.750,Myocardial Infarction,C23.550.513.355.750 - Myocardial Infarction
C23.550.717.489.750,Myocardial Infarction,C23.550.717.489.750 - Myocardial Infarction
C18.452.394.968.500,Insulin Resistance,C18.452.394.968.500 - Insulin Resistance
G07.690.773.984.617,Insulin Resistance,G07.690.773.984.617 - Insulin Resistance
C05.550.069,Ankylosis,C05.550.069 - Ankylosis
D12,"Amino Acids, Peptides, and Proteins","D12 - Amino Acids, Peptides, and Proteins"
D018680,Cholinergic Antagonists,D018680 - Cholinergic Antagonists
F01.393.446,"Identification, Psychological","F01.393.446 - Identification, Psychological"
F01.752.747.385,"Identification, Psychological","F01.752.747.385 - Identification, Psychological"
C18.452.584.500.500,Hyperlipidemias,C18.452.584.500.500 - Hyperlipidemias
F01.393.446.250,Gender Identity,F01.393.446.250 - Gender Identity
F01.752.747.385.200,Gender Identity,F01.752.747.385.200 - Gender Identity
F01.752.747.722.200,Gender Identity,F01.752.747.722.200 - Gender Identity
F02.739.794.793.200,Gender Identity,F02.739.794.793.200 - Gender Identity
D23,Biological Factors,D23 - Biological Factors
C05.550.114,Arthritis,C05.550.114 - Arthritis
D03.383.129.578.075,Atorvastatin,D03.383.129.578.075 - Atorvastatin
D10.251.450.200,Atorvastatin,D10.251.450.200 - Atorvastatin
D019161,Hydroxymethylglutaryl-CoA Reductase Inhibitors,D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors
D27,Chemical Actions and Uses,D27 - Chemical Actions and Uses
D27.505.954.411.918,Vasodilator Agents,D27.505.954.411.918 - Vasodilator Agents
C05.550.870,Synovitis,C05.550.870 - Synovitis
C18.654.521.500.133,Avitaminosis,C18.654.521.500.133 - Avitaminosis
C14.280.945.910,"Ventricular Dysfunction, Right","C14.280.945.910 - Ventricular Dysfunction, Right"
D02.065.884,Sulfonamides,D02.065.884 - Sulfonamides
D02.886.590.700,Sulfonamides,D02.886.590.700 - Sulfonamides
F01.752.747.722,Psychosexual Development,F01.752.747.722 - Psychosexual Development
F02.739.794.793,Psychosexual Development,F02.739.794.793 - Psychosexual Development
F01.752.747,Personality Development,F01.752.747 - Personality Development
C18.654.726.750.500,Obesity,C18.654.726.750.500 - Obesity
C23.888.144.699.500,Obesity,C23.888.144.699.500 - Obesity
E01,Diagnosis,E01 - Diagnosis
D27.505.696.663.850.014,Analgesics,D27.505.696.663.850.014 - Analgesics
D27.505.954.427.040,Analgesics,D27.505.954.427.040 - Analgesics
D02.065,Amides,D02.065 - Amides
D12.644.276.374,Cytokines,D12.644.276.374 - Cytokines
D12.776.467.374,Cytokines,D12.776.467.374 - Cytokines
D23.529.374,Cytokines,D23.529.374 - Cytokines
E02,Therapeutics,E02 - Therapeutics
D02.455.426,"Hydrocarbons, Cyclic","D02.455.426 - Hydrocarbons, Cyclic"
D02.455,Hydrocarbons,D02.455 - Hydrocarbons
F02.463.188,Cognition,F02.463.188 - Cognition
C14.907.137.126,Arteriosclerosis,C14.907.137.126 - Arteriosclerosis
D27.505.954.427.080,Anticonvulsants,D27.505.954.427.080 - Anticonvulsants
F02.739.794,Psychoanalytic Theory,F02.739.794 - Psychoanalytic Theory
C23.888.592.612,Pain,C23.888.592.612 - Pain
F02.830.816.444,Pain,F02.830.816.444 - Pain
G11.561.790.444,Pain,G11.561.790.444 - Pain
C05.550.114.606,Osteoarthritis,C05.550.114.606 - Osteoarthritis
C05.799.613,Osteoarthritis,C05.799.613 - Osteoarthritis
D01.248.497.158.606,Nitrates,D01.248.497.158.606 - Nitrates
D01.625.525.550,Nitrates,D01.625.525.550 - Nitrates
D02.583,Nitrates,D02.583 - Nitrates
D02.455.526,"Hydrocarbons, Halogenated","D02.455.526 - Hydrocarbons, Halogenated"
D12.644.276.624,Fibroblast Growth Factors,D12.644.276.624 - Fibroblast Growth Factors
D12.776.467.624,Fibroblast Growth Factors,D12.776.467.624 - Fibroblast Growth Factors
D23.529.624,Fibroblast Growth Factors,D23.529.624 - Fibroblast Growth Factors
C08.127.108,Asthma,C08.127.108 - Asthma
C08.381.495.108,Asthma,C08.381.495.108 - Asthma
C08.674.095,Asthma,C08.674.095 - Asthma
C20.543.480.680.095,Asthma,C20.543.480.680.095 - Asthma
D27.505.954.502.119,Anticoagulants,D27.505.954.502.119 - Anticoagulants
E03,Anesthesia and Analgesia,E03 - Anesthesia and Analgesia
D02.583.575,Nicorandil,D02.583.575 - Nicorandil
D03.066.515.530.498,Nicorandil,D03.066.515.530.498 - Nicorandil
D03.383.725.547.530.498,Nicorandil,D03.383.725.547.530.498 - Nicorandil
E04,"Surgical Procedures, Operative","E04 - Surgical Procedures, Operative"
F02.830.816,Sensation,F02.830.816 - Sensation
G11.561.790,Sensation,G11.561.790 - Sensation
D02.705,Organophosphorus Compounds,D02.705 - Organophosphorus Compounds
C06.405.117,Esophageal Diseases,C06.405.117 - Esophageal Diseases
C10.228.140.300.150,Brain Ischemia,C10.228.140.300.150 - Brain Ischemia
C14.907.253.092,Brain Ischemia,C14.907.253.092 - Brain Ischemia
D02.705.429,Organophosphonates,D02.705.429 - Organophosphonates
C10.228.140.300.775,Stroke,C10.228.140.300.775 - Stroke
C14.907.253.855,Stroke,C14.907.253.855 - Stroke
D01.875,Sulfur Compounds,D01.875 - Sulfur Compounds
D02.886,Sulfur Compounds,D02.886 - Sulfur Compounds
D27.505.954.502.780,Platelet Aggregation Inhibitors,D27.505.954.502.780 - Platelet Aggregation Inhibitors
E05,Investigative Techniques,E05 - Investigative Techniques
C23.300.707.960.500,"Hernia, Diaphragmatic","C23.300.707.960.500 - Hernia, Diaphragmatic"
C06.405.205,Gastroenteritis,C06.405.205 - Gastroenteritis
D12.644.456.345,Dipeptides,D12.644.456.345 - Dipeptides
C10.228.140.380,Dementia,C10.228.140.380 - Dementia
F03.615.400,Dementia,F03.615.400 - Dementia
F04.711.513.603,Mental Status and Dementia Tests,F04.711.513.603 - Mental Status and Dementia Tests
D01.029.260.700.675.374.425,Phosphoramides,D01.029.260.700.675.374.425 - Phosphoramides
D01.695.625.675.650.425,Phosphoramides,D01.695.625.675.650.425 - Phosphoramides
D02.705.672,Phosphoramides,D02.705.672 - Phosphoramides
E01.370.386.700.650,Pulmonary Gas Exchange,E01.370.386.700.650 - Pulmonary Gas Exchange
G03.143.775.602,Pulmonary Gas Exchange,G03.143.775.602 - Pulmonary Gas Exchange
G09.772.705.760.602,Pulmonary Gas Exchange,G09.772.705.760.602 - Pulmonary Gas Exchange
C06.405.469,Intestinal Diseases,C06.405.469 - Intestinal Diseases
E07,Equipment and Supplies,E07 - Equipment and Supplies
C14.907.355.350,Embolism,C14.907.355.350 - Embolism
D03.066,"Acids, Heterocyclic","D03.066 - Acids, Heterocyclic"
C08.381.495.389,"Pulmonary Disease, Chronic Obstructive","C08.381.495.389 - Pulmonary Disease, Chronic Obstructive"
C23.550.291.500.875,"Pulmonary Disease, Chronic Obstructive","C23.550.291.500.875 - Pulmonary Disease, Chronic Obstructive"
D27.505.954.796.050,Anti-Asthmatic Agents,D27.505.954.796.050 - Anti-Asthmatic Agents
C14.907.355.590,Thromboembolism,C14.907.355.590 - Thromboembolism
D02.886.590,Sulfones,D02.886.590 - Sulfones
F04.711.513,Neuropsychological Tests,F04.711.513 - Neuropsychological Tests
C07.465.625,Oral Hemorrhage,C07.465.625 - Oral Hemorrhage
C23.550.414.922,Oral Hemorrhage,C23.550.414.922 - Oral Hemorrhage
C23.888.619.500,Oral Hemorrhage,C23.888.619.500 - Oral Hemorrhage
F01,Behavior and Behavior Mechanisms,F01 - Behavior and Behavior Mechanisms
D03.132,Alkaloids,D03.132 - Alkaloids
G03.143.775,Respiratory Transport,G03.143.775 - Respiratory Transport
G09.772.705.760,Respiratory Transport,G09.772.705.760 - Respiratory Transport
C14.907.355.830,Thrombosis,C14.907.355.830 - Thrombosis
F02,Psychological Phenomena,F02 - Psychological Phenomena
D03.383,"Heterocyclic Compounds, 1-Ring","D03.383 - Heterocyclic Compounds, 1-Ring"
C23.550.291.937.500,Symptom Flare Up,C23.550.291.937.500 - Symptom Flare Up
D02.886.778,Thiophenes,D02.886.778 - Thiophenes
D03.383.903,Thiophenes,D03.383.903 - Thiophenes
F03,Mental Disorders,F03 - Mental Disorders
G05.346.500,Genetic Profile,G05.346.500 - Genetic Profile
D03.633,"Heterocyclic Compounds, Fused-Ring","D03.633 - Heterocyclic Compounds, Fused-Ring"
C08.381.423,"Hypertension, Pulmonary","C08.381.423 - Hypertension, Pulmonary"
C14.907.489.556,"Hypertension, Pulmonary","C14.907.489.556 - Hypertension, Pulmonary"
F04,Behavioral Disciplines and Activities,F04 - Behavioral Disciplines and Activities
D04.210,Fused-Ring Compounds,D04.210 - Fused-Ring Compounds
D04.345,Macrocyclic Compounds,D04.345 - Macrocyclic Compounds
C08.381.483,"Lung Diseases, Interstitial","C08.381.483 - Lung Diseases, Interstitial"
D03.132.960,Xanthines,D03.132.960 - Xanthines
D03.633.100.759.758.824,Xanthines,D03.633.100.759.758.824 - Xanthines
G03,Metabolism,G03 - Metabolism
D12.776.256,Dietary Proteins,D12.776.256 - Dietary Proteins
G07.203.300.428,Dietary Proteins,G07.203.300.428 - Dietary Proteins
J02.500.428,Dietary Proteins,J02.500.428 - Dietary Proteins
D12.776.034.145,C-Reactive Protein,D12.776.034.145 - C-Reactive Protein
D12.776.124.050.120,C-Reactive Protein,D12.776.124.050.120 - C-Reactive Protein
D12.776.124.486.157,C-Reactive Protein,D12.776.124.486.157 - C-Reactive Protein
G05,Genetic Phenomena,G05 - Genetic Phenomena
E01.370.350.130.625,Coronary Angiography,E01.370.350.130.625 - Coronary Angiography
E01.370.350.700.060.200,Coronary Angiography,E01.370.350.700.060.200 - Coronary Angiography
E01.370.370.050.200,Coronary Angiography,E01.370.370.050.200 - Coronary Angiography
E01.370.370.380.200,Coronary Angiography,E01.370.370.380.200 - Coronary Angiography
D02.455.426.559.847,Polycyclic Aromatic Hydrocarbons,D02.455.426.559.847 - Polycyclic Aromatic Hydrocarbons
D04.615,Polycyclic Aromatic Hydrocarbons,D04.615 - Polycyclic Aromatic Hydrocarbons
G07.203.300.600,Meat,G07.203.300.600 - Meat
J02.500.600,Meat,J02.500.600 - Meat
C08.381.495,"Lung Diseases, Obstructive","C08.381.495 - Lung Diseases, Obstructive"
G07.345.249,Growth,G07.345.249 - Growth
D03.383.129,Azoles,D03.383.129 - Azoles
D10.532.091,Apolipoproteins,D10.532.091 - Apolipoproteins
D12.776.070.400,Apolipoproteins,D12.776.070.400 - Apolipoproteins
D12.776.521.120,Apolipoproteins,D12.776.521.120 - Apolipoproteins
D05.500,Multiprotein Complexes,D05.500 - Multiprotein Complexes
C14.907.355.830.573.750,Raynaud Disease,C14.907.355.830.573.750 - Raynaud Disease
C14.907.617.812,Raynaud Disease,C14.907.617.812 - Raynaud Disease
C17.800.862.406.750,Raynaud Disease,C17.800.862.406.750 - Raynaud Disease
D03.383.606,Piperazines,D03.383.606 - Piperazines
G07,Physiological Phenomena,G07 - Physiological Phenomena
E01.370.350.700.060,Angiography,E01.370.350.700.060 - Angiography
E01.370.370.050,Angiography,E01.370.370.050 - Angiography
D12.776.124.050,Acute-Phase Proteins,D12.776.124.050 - Acute-Phase Proteins
G07.690.773,Pharmacological Phenomena,G07.690.773 - Pharmacological Phenomena
C15.378.100.920,Vitamin K Deficiency,C15.378.100.920 - Vitamin K Deficiency
C15.378.463.841,Vitamin K Deficiency,C15.378.463.841 - Vitamin K Deficiency
C18.654.521.500.133.912,Vitamin K Deficiency,C18.654.521.500.133.912 - Vitamin K Deficiency
G08,Reproductive and Urinary Physiological Phenomena,G08 - Reproductive and Urinary Physiological Phenomena
D03.383.663,Pyrans,D03.383.663 - Pyrans
D05.750,Polymers,D05.750 - Polymers
D25.720,Polymers,D25.720 - Polymers
J01.637.051.720,Polymers,J01.637.051.720 - Polymers
D12.776.124.270,Fibrin,D12.776.124.270 - Fibrin
G07.690.773.984,Drug Resistance,G07.690.773.984 - Drug Resistance
G08.686.157,Climacteric,G08.686.157 - Climacteric
G08.686.841.249,Climacteric,G08.686.841.249 - Climacteric
C23.888.592.612.233,Chest Pain,C23.888.592.612.233 - Chest Pain
D054328,Proton Pump Inhibitors,D054328 - Proton Pump Inhibitors
C23.888.942.343.550,Nocturia,C23.888.942.343.550 - Nocturia
G07.345.750,Sexual Development,G07.345.750 - Sexual Development
G08.686.841,Sexual Development,G08.686.841 - Sexual Development
D03.383.725,Pyridines,D03.383.725 - Pyridines
C08.381.750,Pulmonary Eosinophilia,C08.381.750 - Pulmonary Eosinophilia
C15.378.553.231.549.750,Pulmonary Eosinophilia,C15.378.553.231.549.750 - Pulmonary Eosinophilia
G08.686.157.500,Menopause,G08.686.157.500 - Menopause
G08.686.841.249.500,Menopause,G08.686.841.249.500 - Menopause
G09,Circulatory and Respiratory Physiological Phenomena,G09 - Circulatory and Respiratory Physiological Phenomena
D057911,Angiotensin Receptor Antagonists,D057911 - Angiotensin Receptor Antagonists
G11,Musculoskeletal and Neural Physiological Phenomena,G11 - Musculoskeletal and Neural Physiological Phenomena
E01.370.370.140.049,Ankle Brachial Index,E01.370.370.140.049 - Ankle Brachial Index
C23.888.942.343.600,Prostatism,C23.888.942.343.600 - Prostatism
C08.460.572,Nasal Polyps,C08.460.572 - Nasal Polyps
C09.603.557,Nasal Polyps,C09.603.557 - Nasal Polyps
C23.300.825.557,Nasal Polyps,C23.300.825.557 - Nasal Polyps
D12.776.124.486,Immunoproteins,D12.776.124.486 - Immunoproteins
E01.370.390.400.300,Glomerular Filtration Rate,E01.370.390.400.300 - Glomerular Filtration Rate
G08.852.357,Glomerular Filtration Rate,G08.852.357 - Glomerular Filtration Rate
C15.378.553.231,Eosinophilia,C15.378.553.231 - Eosinophilia
D058666,Adrenergic beta-2 Receptor Agonists,D058666 - Adrenergic beta-2 Receptor Agonists
C12.050.351.968.829.813,"Urinary Bladder, Overactive","C12.050.351.968.829.813 - Urinary Bladder, Overactive"
C12.200.777.829.866,"Urinary Bladder, Overactive","C12.200.777.829.866 - Urinary Bladder, Overactive"
C12.950.829.813,"Urinary Bladder, Overactive","C12.950.829.813 - Urinary Bladder, Overactive"
C23.888.942.343.780,"Urinary Bladder, Overactive","C23.888.942.343.780 - Urinary Bladder, Overactive"
G08.852.898,Urodynamics,G08.852.898 - Urodynamics
D03.383.931,Triazines,D03.383.931 - Triazines
D12.776.124.790,Serum Globulins,D12.776.124.790 - Serum Globulins
D12.776.377.715,Serum Globulins,D12.776.377.715 - Serum Globulins
C01.748.674,Rhinitis,C01.748.674 - Rhinitis
C08.460.799,Rhinitis,C08.460.799 - Rhinitis
C08.730.674,Rhinitis,C08.730.674 - Rhinitis
C09.603.799,Rhinitis,C09.603.799 - Rhinitis
C14.240.400,"Heart Defects, Congenital","C14.240.400 - Heart Defects, Congenital"
C14.280.400,"Heart Defects, Congenital","C14.280.400 - Heart Defects, Congenital"
C16.131.240.400,"Heart Defects, Congenital","C16.131.240.400 - Heart Defects, Congenital"
H02,Health Occupations,H02 - Health Occupations
E01.370.370.380.150,Cardiac Output,E01.370.370.380.150 - Cardiac Output
G09.330.380.124,Cardiac Output,G09.330.380.124 - Cardiac Output
E05.830.250,Hemorheology,E05.830.250 - Hemorheology
G09.188.370,Hemorheology,G09.188.370 - Hemorheology
G09.330.380.630,Hemorheology,G09.330.380.630 - Hemorheology
C12.050.351.968.934.814,Urinary Incontinence,C12.050.351.968.934.814 - Urinary Incontinence
C12.200.777.934.852,Urinary Incontinence,C12.200.777.934.852 - Urinary Incontinence
C12.950.934.814,Urinary Incontinence,C12.950.934.814 - Urinary Incontinence
C23.888.942.343.800,Urinary Incontinence,C23.888.942.343.800 - Urinary Incontinence
F04.096.879,Social Sciences,F04.096.879 - Social Sciences
I01,Social Sciences,I01 - Social Sciences
D12.776.210.500,Muscle Proteins,D12.776.210.500 - Muscle Proteins
C12.050.351.968.419.570.363.680,Lupus Nephritis,C12.050.351.968.419.570.363.680 - Lupus Nephritis
C12.200.777.419.570.363.680,Lupus Nephritis,C12.200.777.419.570.363.680 - Lupus Nephritis
C12.950.419.570.363.680,Lupus Nephritis,C12.950.419.570.363.680 - Lupus Nephritis
C17.300.480.680,Lupus Nephritis,C17.300.480.680 - Lupus Nephritis
C20.111.590.560,Lupus Nephritis,C20.111.590.560 - Lupus Nephritis
D03.633.100,"Heterocyclic Compounds, 2-Ring","D03.633.100 - Heterocyclic Compounds, 2-Ring"
C08.618.326,Dyspnea,C08.618.326 - Dyspnea
C23.888.852.371,Dyspnea,C23.888.852.371 - Dyspnea
G09.330.100.248,Collateral Circulation,G09.330.100.248 - Collateral Circulation
D04.210.500,Steroids,D04.210.500 - Steroids
I03,Human Activities,I03 - Human Activities
E01.370.370.380.240,Electrocardiography,E01.370.370.380.240 - Electrocardiography
E01.370.405.240,Electrocardiography,E01.370.405.240 - Electrocardiography
E01.370.600.875.249,Blood Pressure,E01.370.600.875.249 - Blood Pressure
G09.330.380.076,Blood Pressure,G09.330.380.076 - Blood Pressure
G09.330.100,Blood Circulation,G09.330.100 - Blood Circulation
E01.370.350.850.708.500,Carotid Intima-Media Thickness,E01.370.350.850.708.500 - Carotid Intima-Media Thickness
E01.370.370.180,Carotid Intima-Media Thickness,E01.370.370.180 - Carotid Intima-Media Thickness
G09.330.210,Carotid Intima-Media Thickness,G09.330.210 - Carotid Intima-Media Thickness
J02,Food and Beverages,J02 - Food and Beverages
D04.345.566,"Peptides, Cyclic","D04.345.566 - Peptides, Cyclic"
D12.644.641,"Peptides, Cyclic","D12.644.641 - Peptides, Cyclic"
E01.370.386.700.485,Lung Volume Measurements,E01.370.386.700.485 - Lung Volume Measurements
D01.268.558.362.484,Gadolinium,D01.268.558.362.484 - Gadolinium
D01.552.550.399.484,Gadolinium,D01.552.550.399.484 - Gadolinium
D08.622,Enzyme Precursors,D08.622 - Enzyme Precursors
D12.776.811.243,Enzyme Precursors,D12.776.811.243 - Enzyme Precursors
D12.776.256.159,"Animal Proteins, Dietary","D12.776.256.159 - Animal Proteins, Dietary"
G07.203.300.428.159,"Animal Proteins, Dietary","G07.203.300.428.159 - Animal Proteins, Dietary"
J02.500.428.159,"Animal Proteins, Dietary","J02.500.428.159 - Animal Proteins, Dietary"
C17.800.859.575,Parapsoriasis,C17.800.859.575 - Parapsoriasis
D02.455.426.559.847.638,Naphthalenes,D02.455.426.559.847.638 - Naphthalenes
D04.615.638,Naphthalenes,D04.615.638 - Naphthalenes
K01,Humanities,K01 - Humanities
G09.330.380,Hemodynamics,G09.330.380 - Hemodynamics
E01.370.600.875.500,Heart Rate,E01.370.600.875.500 - Heart Rate
G09.330.380.500,Heart Rate,G09.330.380.500 - Heart Rate
D08.811,Enzymes,D08.811 - Enzymes
D12.776.256.159.313.250,"Fish Proteins, Dietary","D12.776.256.159.313.250 - Fish Proteins, Dietary"
D12.776.325.250,"Fish Proteins, Dietary","D12.776.325.250 - Fish Proteins, Dietary"
G07.203.300.428.159.313.250,"Fish Proteins, Dietary","G07.203.300.428.159.313.250 - Fish Proteins, Dietary"
G07.203.300.600.625.250,"Fish Proteins, Dietary","G07.203.300.600.625.250 - Fish Proteins, Dietary"
G07.203.300.600.875.550,"Fish Proteins, Dietary","G07.203.300.600.875.550 - Fish Proteins, Dietary"
J02.500.428.159.375.250,"Fish Proteins, Dietary","J02.500.428.159.375.250 - Fish Proteins, Dietary"
J02.500.600.625.250,"Fish Proteins, Dietary","J02.500.600.625.250 - Fish Proteins, Dietary"
J02.500.600.875.550,"Fish Proteins, Dietary","J02.500.600.875.550 - Fish Proteins, Dietary"
D05.500.945,Troponin,D05.500.945 - Troponin
D05.750.078.730.825,Troponin,D05.750.078.730.825 - Troponin
D12.776.210.500.910,Troponin,D12.776.210.500.910 - Troponin
D12.776.220.525.825,Troponin,D12.776.220.525.825 - Troponin
E01.370.386.700.660,Pulmonary Ventilation,E01.370.386.700.660 - Pulmonary Ventilation
G09.772.650,Pulmonary Ventilation,G09.772.650 - Pulmonary Ventilation
C17.800.859.675,Psoriasis,C17.800.859.675 - Psoriasis
M01,Persons,M01 - Persons
D09.400,Glycoconjugates,D09.400 - Glycoconjugates
D02.455.426.559.389,Benzene Derivatives,D02.455.426.559.389 - Benzene Derivatives
C10.114.375,"Demyelinating Autoimmune Diseases, CNS","C10.114.375 - Demyelinating Autoimmune Diseases, CNS"
C10.228.140.695.562,"Demyelinating Autoimmune Diseases, CNS","C10.228.140.695.562 - Demyelinating Autoimmune Diseases, CNS"
C10.314.350,"Demyelinating Autoimmune Diseases, CNS","C10.314.350 - Demyelinating Autoimmune Diseases, CNS"
C20.111.258.250,"Demyelinating Autoimmune Diseases, CNS","C20.111.258.250 - Demyelinating Autoimmune Diseases, CNS"
E01.370.386.700.485.750.900,Vital Capacity,E01.370.386.700.485.750.900 - Vital Capacity
G09.772.850.970,Vital Capacity,G09.772.850.970 - Vital Capacity
C17.800.862.945,Urticaria,C17.800.862.945 - Urticaria
C20.543.480.904,Urticaria,C20.543.480.904 - Urticaria
G09.772.705,Respiration,G09.772.705 - Respiration
N01,Population Characteristics,N01 - Population Characteristics
D09.698,Polysaccharides,D09.698 - Polysaccharides
E01.370.225.124.100.115,Blood Urea Nitrogen,E01.370.225.124.100.115 - Blood Urea Nitrogen
E01.370.390.400.100,Blood Urea Nitrogen,E01.370.390.400.100 - Blood Urea Nitrogen
E05.200.124.100.115,Blood Urea Nitrogen,E05.200.124.100.115 - Blood Urea Nitrogen
D05.750.078,Biopolymers,D05.750.078 - Biopolymers
D25.720.099,Biopolymers,D25.720.099 - Biopolymers
J01.637.051.720.099,Biopolymers,J01.637.051.720.099 - Biopolymers
E01.370.386.700.485.750,Total Lung Capacity,E01.370.386.700.485.750 - Total Lung Capacity
G09.772.850,Total Lung Capacity,G09.772.850 - Total Lung Capacity
C05.116.198.579,Osteoporosis,C05.116.198.579 - Osteoporosis
C18.452.104.579,Osteoporosis,C18.452.104.579 - Osteoporosis
D02.455.526.728.650,Nitrogen Mustard Compounds,D02.455.526.728.650 - Nitrogen Mustard Compounds
F01.145.632,Motor Activity,F01.145.632 - Motor Activity
G11.427.410.698,Motor Activity,G11.427.410.698 - Motor Activity
D12.776.422.316,Globins,D12.776.422.316 - Globins
N02,"Health Care Facilities, Manpower, and Services","N02 - Health Care Facilities, Manpower, and Services"
C10.228.140,Brain Diseases,C10.228.140 - Brain Diseases
D06.347.700,Mineralocorticoid Receptor Antagonists,D06.347.700 - Mineralocorticoid Receptor Antagonists
D27.505.696.399.450.600,Mineralocorticoid Receptor Antagonists,D27.505.696.399.450.600 - Mineralocorticoid Receptor Antagonists
D27.505.696.560.500.726.249,Mineralocorticoid Receptor Antagonists,D27.505.696.560.500.726.249 - Mineralocorticoid Receptor Antagonists
D09.947,Sugars,D09.947 - Sugars
D02.705.429.500.100,Alendronate,D02.705.429.500.100 - Alendronate
E01.370.600.425.500,Hand Strength,E01.370.600.425.500 - Hand Strength
G11.427.560.500,Hand Strength,G11.427.560.500 - Hand Strength
N05,"Health Care Quality, Access, and Evaluation","N05 - Health Care Quality, Access, and Evaluation"
C10.228.662,Movement Disorders,C10.228.662 - Movement Disorders
G07.568,Movement,G07.568 - Movement
G11.427.410,Movement,G11.427.410 - Movement
C18.452.174.451,Hypercalcemia,C18.452.174.451 - Hypercalcemia
C18.452.950.340,Hypercalcemia,C18.452.950.340 - Hypercalcemia
D10.212,Fats,D10.212 - Fats
D06.472.040,Adrenal Cortex Hormones,D06.472.040 - Adrenal Cortex Hormones
E01.370.600.425,Muscle Strength,E01.370.600.425 - Muscle Strength
G11.427.560,Muscle Strength,G11.427.560 - Muscle Strength
D06.472.334,Gonadal Hormones,D06.472.334 - Gonadal Hormones
D10.251,Fatty Acids,D10.251 - Fatty Acids
N06,Environment and Public Health,N06 - Environment and Public Health
C18.452.394.750,Diabetes Mellitus,C18.452.394.750 - Diabetes Mellitus
C19.246,Diabetes Mellitus,C19.246 - Diabetes Mellitus
D02.455.526.728.650.730.243,Cyclophosphamide,D02.455.526.728.650.730.243 - Cyclophosphamide
D02.705.672.500.243,Cyclophosphamide,D02.705.672.500.243 - Cyclophosphamide
Y05,etiology,Y05 - etiology
D06.472.699,Peptide Hormones,D06.472.699 - Peptide Hormones
D12.644.548,Peptide Hormones,D12.644.548 - Peptide Hormones
D10.532,Lipoproteins,D10.532 - Lipoproteins
D12.776.521,Lipoproteins,D12.776.521 - Lipoproteins
C18.452.394.952,Hyperglycemia,C18.452.394.952 - Hyperglycemia
D08.811.520.650.600,Guanylate Cyclase,D08.811.520.650.600 - Guanylate Cyclase
D12.776.476.350,Guanylate Cyclase,D12.776.476.350 - Guanylate Cyclase
H02.403.810,"Specialties, Surgical","H02.403.810 - Specialties, Surgical"
D10.627,Oils,D10.627 - Oils
C18.452.394.968,Hyperinsulinism,C18.452.394.968 - Hyperinsulinism
Z01,Geographic Locations,Z01 - Geographic Locations
C10.574.928,Synucleinopathies,C10.574.928 - Synucleinopathies
C18.452.845.650,Synucleinopathies,C18.452.845.650 - Synucleinopathies
D12.776.256.159.313,Meat Proteins,D12.776.256.159.313 - Meat Proteins
G07.203.300.428.159.313,Meat Proteins,G07.203.300.428.159.313 - Meat Proteins
G07.203.300.600.625,Meat Proteins,G07.203.300.600.625 - Meat Proteins
J02.500.428.159.375,Meat Proteins,J02.500.428.159.375 - Meat Proteins
J02.500.600.625,Meat Proteins,J02.500.600.625 - Meat Proteins
D02.065.884.863,Tamsulosin,D02.065.884.863 - Tamsulosin
D02.886.590.700.863,Tamsulosin,D02.886.590.700.863 - Tamsulosin
C12.050.351,Female Urogenital Diseases,C12.050.351 - Female Urogenital Diseases
D02.455.426.559.389.185.475,Losartan,D02.455.426.559.389.185.475 - Losartan
D03.383.129.308.507,Losartan,D03.383.129.308.507 - Losartan
D03.383.129.617.467,Losartan,D03.383.129.617.467 - Losartan
K01.752.400,Life,K01.752.400 - Life
E02.148.050.060.100,"Angioplasty, Balloon, Coronary","E02.148.050.060.100 - Angioplasty, Balloon, Coronary"
E04.100.376.719.100,"Angioplasty, Balloon, Coronary","E04.100.376.719.100 - Angioplasty, Balloon, Coronary"
E04.100.814.529.124.060.100,"Angioplasty, Balloon, Coronary","E04.100.814.529.124.060.100 - Angioplasty, Balloon, Coronary"
E04.100.814.529.968.050,"Angioplasty, Balloon, Coronary","E04.100.814.529.968.050 - Angioplasty, Balloon, Coronary"
E04.502.382.124.060.100,"Angioplasty, Balloon, Coronary","E04.502.382.124.060.100 - Angioplasty, Balloon, Coronary"
E04.502.382.968.050,"Angioplasty, Balloon, Coronary","E04.502.382.968.050 - Angioplasty, Balloon, Coronary"
E04.928.220.520.100,"Angioplasty, Balloon, Coronary","E04.928.220.520.100 - Angioplasty, Balloon, Coronary"
E05.157.016.060.100,"Angioplasty, Balloon, Coronary","E05.157.016.060.100 - Angioplasty, Balloon, Coronary"
D23.101,Biomarkers,D23.101 - Biomarkers
A02.835,Skeleton,A02.835 - Skeleton
C18.452.950.565,Hypokalemia,C18.452.950.565 - Hypokalemia
D09.400.430,Glycoproteins,D09.400.430 - Glycoproteins
D12.776.395,Glycoproteins,D12.776.395 - Glycoproteins
A03.556,Gastrointestinal Tract,A03.556 - Gastrointestinal Tract
D12.644.276,Intercellular Signaling Peptides and Proteins,D12.644.276 - Intercellular Signaling Peptides and Proteins
D12.776.467,Intercellular Signaling Peptides and Proteins,D12.776.467 - Intercellular Signaling Peptides and Proteins
D23.529,Intercellular Signaling Peptides and Proteins,D23.529 - Intercellular Signaling Peptides and Proteins
D09.698.373,Glycosaminoglycans,D09.698.373 - Glycosaminoglycans
C12.100.500,"Genital Diseases, Male","C12.100.500 - Genital Diseases, Male"
C12.200.294,"Genital Diseases, Male","C12.200.294 - Genital Diseases, Male"
D12.776.124.050.250,Fibrinogen,D12.776.124.050.250 - Fibrinogen
D12.776.124.125.500,Fibrinogen,D12.776.124.125.500 - Fibrinogen
D12.776.811.300,Fibrinogen,D12.776.811.300 - Fibrinogen
D23.119.490,Fibrinogen,D23.119.490 - Fibrinogen
E04.100.376.719.332,Coronary Artery Bypass,E04.100.376.719.332 - Coronary Artery Bypass
E04.100.814.868.750,Coronary Artery Bypass,E04.100.814.868.750 - Coronary Artery Bypass
E04.928.220.520.220,Coronary Artery Bypass,E04.928.220.520.220 - Coronary Artery Bypass
D02.886.675.274,Febuxostat,D02.886.675.274 - Febuxostat
D03.383.129.708.274,Febuxostat,D03.383.129.708.274 - Febuxostat
D27.505,Pharmacologic Actions,D27.505 - Pharmacologic Actions
D03.383.663.283.909,Vitamin E,D03.383.663.283.909 - Vitamin E
D03.633.100.150.909,Vitamin E,D03.633.100.150.909 - Vitamin E
C12.100.875,"Sexual Dysfunction, Physiological","C12.100.875 - Sexual Dysfunction, Physiological"
D06.472.699.587.200.500,Proinsulin,D06.472.699.587.200.500 - Proinsulin
D12.644.548.586.200.500,Proinsulin,D12.644.548.586.200.500 - Proinsulin
D12.776.811.706,Proinsulin,D12.776.811.706 - Proinsulin
D09.947.875,Monosaccharides,D09.947.875 - Monosaccharides
N01.824.196,Educational Status,N01.824.196 - Educational Status
C18.654.521.500,Deficiency Diseases,C18.654.521.500 - Deficiency Diseases
A07.015,Blood Vessels,A07.015 - Blood Vessels
C18.654.726.750,Overweight,C18.654.726.750 - Overweight
C23.888.144.699,Overweight,C23.888.144.699 - Overweight
E01.370.600.115.450.375.699,Overweight,E01.370.600.115.450.375.699 - Overweight
G07.100.100.160.120.699,Overweight,G07.100.100.160.120.699 - Overweight
G07.100.175.313.699,Overweight,G07.100.175.313.699 - Overweight
E01.370,Diagnostic Techniques and Procedures,E01.370 - Diagnostic Techniques and Procedures
D12.776.860.300,Extracellular Matrix Proteins,D12.776.860.300 - Extracellular Matrix Proteins
D03.066.515.475,Niacin,D03.066.515.475 - Niacin
D03.383.725.547.475,Niacin,D03.383.725.547.475 - Niacin
A07.541,Heart,A07.541 - Heart
N02.278.306,Health Facility Size,N02.278.306 - Health Facility Size
N05.300.430.410,Health Facility Size,N05.300.430.410 - Health Facility Size
D10.212.302,Dietary Fats,D10.212.302 - Dietary Fats
G07.203.300.375,Dietary Fats,G07.203.300.375 - Dietary Fats
J02.500.375,Dietary Fats,J02.500.375 - Dietary Fats
A18.024,"Plant Components, Aerial","A18.024 - Plant Components, Aerial"
E01.789,Prognosis,E01.789 - Prognosis
D03.066.515.530,Niacinamide,D03.066.515.530 - Niacinamide
D03.383.725.547.530,Niacinamide,D03.383.725.547.530 - Niacinamide
E02.760,Patient Care,E02.760 - Patient Care
N02.421.585,Patient Care,N02.421.585 - Patient Care
D10.251.355,"Fatty Acids, Unsaturated","D10.251.355 - Fatty Acids, Unsaturated"
N05.715.350.075,Age Factors,N05.715.350.075 - Age Factors
N06.850.490.250,Age Factors,N06.850.490.250 - Age Factors
D08.811.277.656.300.760.442.750,Prostate-Specific Antigen,D08.811.277.656.300.760.442.750 - Prostate-Specific Antigen
D08.811.277.656.959.350.442.750,Prostate-Specific Antigen,D08.811.277.656.959.350.442.750 - Prostate-Specific Antigen
D12.776.869.250.249.500,Prostate-Specific Antigen,D12.776.869.250.249.500 - Prostate-Specific Antigen
D23.050.285.625,Prostate-Specific Antigen,D23.050.285.625 - Prostate-Specific Antigen
D23.101.140.625,Prostate-Specific Antigen,D23.101.140.625 - Prostate-Specific Antigen
N05.715.350.200,Causality,N05.715.350.200 - Causality
N06.850.490.625,Causality,N06.850.490.625 - Causality
N05.715.350,Epidemiologic Factors,N05.715.350 - Epidemiologic Factors
N06.850.490,Epidemiologic Factors,N06.850.490 - Epidemiologic Factors
D10.251.450,Heptanoic Acids,D10.251.450 - Heptanoic Acids
B03.440,Gram-Negative Bacteria,B03.440 - Gram-Negative Bacteria
E02.095,Biological Therapy,E02.095 - Biological Therapy
D03.633.100.079.080,Benzodiazepines,D03.633.100.079.080 - Benzodiazepines
B03.660,Proteobacteria,B03.660 - Proteobacteria
N05.715.360,Health Care Evaluation Mechanisms,N05.715.360 - Health Care Evaluation Mechanisms
N05.715.350.225,Comorbidity,N05.715.350.225 - Comorbidity
N06.850.490.687,Comorbidity,N06.850.490.687 - Comorbidity
E02.148,Catheterization,E02.148 - Catheterization
E05.157,Catheterization,E05.157 - Catheterization
C08.674,Respiratory Hypersensitivity,C08.674 - Respiratory Hypersensitivity
C20.543.480.680,Respiratory Hypersensitivity,C20.543.480.680 - Respiratory Hypersensitivity
D10.627.430,Fish Oils,D10.627.430 - Fish Oils
E02.319,Drug Therapy,E02.319 - Drug Therapy
D03.633.100.127.075,Amiodarone,D03.633.100.127.075 - Amiodarone
D27.505.519.162,Angiotensin Receptor Antagonists,D27.505.519.162 - Angiotensin Receptor Antagonists
N06.850.505,Epidemiologic Measurements,N06.850.505 - Epidemiologic Measurements
C01.748,Respiratory Tract Infections,C01.748 - Respiratory Tract Infections
C08.730,Respiratory Tract Infections,C08.730 - Respiratory Tract Infections
E02.491,Glycemic Control,E02.491 - Glycemic Control
E02.718,Orthopedic Procedures,E02.718 - Orthopedic Procedures
E04.555,Orthopedic Procedures,E04.555 - Orthopedic Procedures
D03.633.100.759.758,Purinones,D03.633.100.759.758 - Purinones
D12.644.400,Neuropeptides,D12.644.400 - Neuropeptides
D12.776.631.650,Neuropeptides,D12.776.631.650 - Neuropeptides
E05.318,Epidemiologic Methods,E05.318 - Epidemiologic Methods
N06.850.520,Epidemiologic Methods,N06.850.520 - Epidemiologic Methods
C05.116,Bone Diseases,C05.116 - Bone Diseases
D27.505.519.186,Antimetabolites,D27.505.519.186 - Antimetabolites
D27.888.569.042,Antimetabolites,D27.888.569.042 - Antimetabolites
C23.300.707.960,Internal Hernia,C23.300.707.960 - Internal Hernia
E01.370.600.115.100.160.560,Waist Circumference,E01.370.600.115.100.160.560 - Waist Circumference
E05.041.124.160.875,Waist Circumference,E05.041.124.160.875 - Waist Circumference
G07.100.100.160.560,Waist Circumference,G07.100.100.160.560 - Waist Circumference
A02.835.232.834,Spine,A02.835.232.834 - Spine
D12.644.456,Oligopeptides,D12.644.456 - Oligopeptides
C05.550,Joint Diseases,C05.550 - Joint Diseases
C14.280.195,Cardiomegaly,C14.280.195 - Cardiomegaly
C23.300.775.250,Cardiomegaly,C23.300.775.250 - Cardiomegaly
D27.505.519.389,Enzyme Inhibitors,D27.505.519.389 - Enzyme Inhibitors
D27.505.519.421,Fibrin Modulating Agents,D27.505.519.421 - Fibrin Modulating Agents
C05.799,Rheumatic Diseases,C05.799 - Rheumatic Diseases
C17.300.775,Rheumatic Diseases,C17.300.775 - Rheumatic Diseases
E02.774,Phototherapy,E02.774 - Phototherapy
A03.556.124.526,"Intestine, Large","A03.556.124.526 - Intestine, Large"
A03.556.249.249,"Intestine, Large","A03.556.249.249 - Intestine, Large"
E05.318.740.225,Biometry,E05.318.740.225 - Biometry
N06.850.505.200,Biometry,N06.850.505.200 - Biometry
D04.210.500.054.079,Androstenes,D04.210.500.054.079 - Androstenes
D27.505.519.562,Membrane Transport Modulators,D27.505.519.562 - Membrane Transport Modulators
D02.455.426.559.847.638.400.900,Simvastatin,D02.455.426.559.847.638.400.900 - Simvastatin
D04.615.638.400.900,Simvastatin,D04.615.638.400.900 - Simvastatin
A03.556.124.684,"Intestine, Small","A03.556.124.684 - Intestine, Small"
C06.405,Gastrointestinal Diseases,C06.405 - Gastrointestinal Diseases
E03.155,Anesthesia,E03.155 - Anesthesia
D27.505.519.625,Neurotransmitter Agents,D27.505.519.625 - Neurotransmitter Agents
D27.505.696.577,Neurotransmitter Agents,D27.505.696.577 - Neurotransmitter Agents
E04.100,Cardiovascular Surgical Procedures,E04.100 - Cardiovascular Surgical Procedures
C07.465,Mouth Diseases,C07.465 - Mouth Diseases
A03.556.124.684.249,Ileum,A03.556.124.684.249 - Ileum
A03.556.249.124,Ileum,A03.556.249.124 - Ileum
E01.370.225.124.100.355,Glucose Tolerance Test,E01.370.225.124.100.355 - Glucose Tolerance Test
E01.370.374.355,Glucose Tolerance Test,E01.370.374.355 - Glucose Tolerance Test
E05.200.124.100.355,Glucose Tolerance Test,E05.200.124.100.355 - Glucose Tolerance Test
C23.550.291.500,Chronic Disease,C23.550.291.500 - Chronic Disease
D12.776.034,Albumins,D12.776.034 - Albumins
D06.472.334.851.968,Testosterone Congeners,D06.472.334.851.968 - Testosterone Congeners
E01.370.225.625.115.320,International Normalized Ratio,E01.370.225.625.115.320 - International Normalized Ratio
E05.200.625.115.320,International Normalized Ratio,E05.200.625.115.320 - International Normalized Ratio
E04.210,Digestive System Surgical Procedures,E04.210 - Digestive System Surgical Procedures
C23.550.291.937,Recurrence,C23.550.291.937 - Recurrence
C14.280.383,Heart Arrest,C14.280.383 - Heart Arrest
A03.556.124.526.356,Colon,A03.556.124.526.356 - Colon
A03.556.249.249.356,Colon,A03.556.249.249.356 - Colon
C08.127,Bronchial Diseases,C08.127 - Bronchial Diseases
D12.776.070,Apoproteins,D12.776.070 - Apoproteins
D27.505.696.260,Calcium-Regulating Hormones and Agents,D27.505.696.260 - Calcium-Regulating Hormones and Agents
D06.472.699.584.625,"Natriuretic Peptide, Brain","D06.472.699.584.625 - Natriuretic Peptide, Brain"
D12.644.548.585.625,"Natriuretic Peptide, Brain","D12.644.548.585.625 - Natriuretic Peptide, Brain"
D12.776.631.590,"Natriuretic Peptide, Brain","D12.776.631.590 - Natriuretic Peptide, Brain"
C23.550.325.500,Subcutaneous Emphysema,C23.550.325.500 - Subcutaneous Emphysema
E05.318.740.600.800,Risk,E05.318.740.600.800 - Risk
G17.680.750,Risk,G17.680.750 - Risk
N05.715.360.750.625.700,Risk,N05.715.360.750.625.700 - Risk
N06.850.520.830.600.800,Risk,N06.850.520.830.600.800 - Risk
C08.381,Lung Diseases,C08.381 - Lung Diseases
E04.292,Extracorporeal Circulation,E04.292 - Extracorporeal Circulation
A07.015.114.269,Coronary Vessels,A07.015.114.269 - Coronary Vessels
A07.015.908.194,Coronary Vessels,A07.015.908.194 - Coronary Vessels
D12.776.124,Blood Proteins,D12.776.124 - Blood Proteins
D06.472.699.587.200,Insulins,D06.472.699.587.200 - Insulins
D12.644.548.586.200,Insulins,D12.644.548.586.200 - Insulins
E04.502,Minimally Invasive Surgical Procedures,E04.502 - Minimally Invasive Surgical Procedures
C08.381.483.652,Pulmonary Fibrosis,C08.381.483.652 - Pulmonary Fibrosis
C23.550.355.644,Pulmonary Fibrosis,C23.550.355.644 - Pulmonary Fibrosis
C08.460,Nose Diseases,C08.460 - Nose Diseases
C09.603,Nose Diseases,C09.603 - Nose Diseases
D27.505.696.422,Hypoglycemic Agents,D27.505.696.422 - Hypoglycemic Agents
C14.280.434,Heart Failure,C14.280.434 - Heart Failure
D12.776.210,Contractile Proteins,D12.776.210 - Contractile Proteins
A11.497.248,"Germ Cells, Plant","A11.497.248 - Germ Cells, Plant"
A18.024.249.500.249,"Germ Cells, Plant","A18.024.249.500.249 - Germ Cells, Plant"
A07.541.358.100,Atrial Appendage,A07.541.358.100 - Atrial Appendage
C08.618,Respiration Disorders,C08.618 - Respiration Disorders
D06.472.699.631.692,"Pituitary Hormones, Posterior","D06.472.699.631.692 - Pituitary Hormones, Posterior"
D12.644.548.691.692,"Pituitary Hormones, Posterior","D12.644.548.691.692 - Pituitary Hormones, Posterior"
D27.505.696.477,Immunologic Factors,D27.505.696.477 - Immunologic Factors
C14.280.484,Heart Valve Diseases,C14.280.484 - Heart Valve Diseases
D12.776.220,Cytoskeletal Proteins,D12.776.220 - Cytoskeletal Proteins
D27.505.696.560,Natriuretic Agents,D27.505.696.560 - Natriuretic Agents
D27.505.954.411.455,Natriuretic Agents,D27.505.954.411.455 - Natriuretic Agents
A18.024.249.500,Flowers,A18.024.249.500 - Flowers
E04.650,Prosthesis Implantation,E04.650 - Prosthesis Implantation
C14.280.647,Myocardial Ischemia,C14.280.647 - Myocardial Ischemia
C14.907.585,Myocardial Ischemia,C14.907.585 - Myocardial Ischemia
D08.811.277.656.300,Endopeptidases,D08.811.277.656.300 - Endopeptidases
C23.550.513.355,Infarction,C23.550.513.355 - Infarction
C23.550.717.489,Infarction,C23.550.717.489 - Infarction
F01.145.805.063.500,Water Pipe Smoking,F01.145.805.063.500 - Water Pipe Smoking
B03.660.150.235.500,Helicobacteraceae,B03.660.150.235.500 - Helicobacteraceae
C05.116.540.310.800,Osteophyte,C05.116.540.310.800 - Osteophyte
D08.811.277.656.675,Metalloproteases,D08.811.277.656.675 - Metalloproteases
D12.776.325,Fish Proteins,D12.776.325 - Fish Proteins
E04.928,Thoracic Surgical Procedures,E04.928 - Thoracic Surgical Procedures
C14.280.945,Ventricular Dysfunction,C14.280.945 - Ventricular Dysfunction
B03.440.500.550,Helicobacter pylori,B03.440.500.550 - Helicobacter pylori
B03.660.150.235.500.250.550,Helicobacter pylori,B03.660.150.235.500.250.550 - Helicobacter pylori
F01.145.805.375.750,Cigarette Smoking,F01.145.805.375.750 - Cigarette Smoking
F01.145.958.875.750,Cigarette Smoking,F01.145.958.875.750 - Cigarette Smoking
D08.811.277.656.837,Proprotein Convertases,D08.811.277.656.837 - Proprotein Convertases
C05.116.900.853.625,Spondylarthritis,C05.116.900.853.625 - Spondylarthritis
C05.550.114.865,Spondylarthritis,C05.550.114.865 - Spondylarthritis
D27.505.696.663,Peripheral Nervous System Agents,D27.505.696.663 - Peripheral Nervous System Agents
D12.776.377,Globulins,D12.776.377 - Globulins
E01.370.600.024,Anthropometry,E01.370.600.024 - Anthropometry
E05.041,Anthropometry,E05.041 - Anthropometry
N06.850.505.200.100,Anthropometry,N06.850.505.200.100 - Anthropometry
B03.660.150.235,Campylobacterales,B03.660.150.235 - Campylobacterales
D08.811.277.656.959,Serine Proteases,D08.811.277.656.959 - Serine Proteases
C05.116.900.853.625.800,Spondylarthropathies,C05.116.900.853.625.800 - Spondylarthropathies
C05.550.114.865.800,Spondylarthropathies,C05.550.114.865.800 - Spondylarthropathies
C14.907.137,Arterial Occlusive Diseases,C14.907.137 - Arterial Occlusive Diseases
D27.505.954.122,Anti-Infective Agents,D27.505.954.122 - Anti-Infective Agents
C10.597.606,Neurobehavioral Manifestations,C10.597.606 - Neurobehavioral Manifestations
C23.888.592.604,Neurobehavioral Manifestations,C23.888.592.604 - Neurobehavioral Manifestations
F01.700,Neurobehavioral Manifestations,F01.700 - Neurobehavioral Manifestations
E01.370.225,Clinical Laboratory Techniques,E01.370.225 - Clinical Laboratory Techniques
E05.200,Clinical Laboratory Techniques,E05.200 - Clinical Laboratory Techniques
D12.776.422,Hemeproteins,D12.776.422 - Hemeproteins
C06.405.205.265.231,"Colitis, Ulcerative","C06.405.205.265.231 - Colitis, Ulcerative"
C06.405.205.731.249,"Colitis, Ulcerative","C06.405.205.731.249 - Colitis, Ulcerative"
C06.405.469.158.188.231,"Colitis, Ulcerative","C06.405.469.158.188.231 - Colitis, Ulcerative"
C06.405.469.432.249,"Colitis, Ulcerative","C06.405.469.432.249 - Colitis, Ulcerative"
C10.228.140.300,Cerebrovascular Disorders,C10.228.140.300 - Cerebrovascular Disorders
C14.907.253,Cerebrovascular Disorders,C14.907.253 - Cerebrovascular Disorders
C10.228,Central Nervous System Diseases,C10.228 - Central Nervous System Diseases
D27.505.954.158,Anti-Inflammatory Agents,D27.505.954.158 - Anti-Inflammatory Agents
D27.505.954.329,Antirheumatic Agents,D27.505.954.329 - Antirheumatic Agents
D08.811.913.696.640,Phosphotransferases (Nitrogenous Group Acceptor),D08.811.913.696.640 - Phosphotransferases (Nitrogenous Group Acceptor)
C14.907.355,Embolism and Thrombosis,C14.907.355 - Embolism and Thrombosis
C05.116.540.310,Exostoses,C05.116.540.310 - Exostoses
C10.314,Demyelinating Diseases,C10.314 - Demyelinating Diseases
D12.644.360,Intracellular Signaling Peptides and Proteins,D12.644.360 - Intracellular Signaling Peptides and Proteins
D12.776.476,Intracellular Signaling Peptides and Proteins,D12.776.476 - Intracellular Signaling Peptides and Proteins
C10.574,Neurodegenerative Diseases,C10.574 - Neurodegenerative Diseases
E05.680,Perfusion,E05.680 - Perfusion
C14.907.489,Hypertension,C14.907.489 - Hypertension
D09.698.373.400.300,"Heparin, Low-Molecular-Weight","D09.698.373.400.300 - Heparin, Low-Molecular-Weight"
C06.405.205.731.500,Crohn Disease,C06.405.205.731.500 - Crohn Disease
C06.405.469.432.500,Crohn Disease,C06.405.469.432.500 - Crohn Disease
D27.505.954.411,Cardiovascular Agents,D27.505.954.411 - Cardiovascular Agents
E07.305,Electrical Equipment and Supplies,E07.305 - Electrical Equipment and Supplies
C23.888.821.525,Heartburn,C23.888.821.525 - Heartburn
D09.947.875.359.250,Fructose,D09.947.875.359.250 - Fructose
D09.947.875.465.354,Fructose,D09.947.875.465.354 - Fructose
C06.405.205.265,Colitis,C06.405.205.265 - Colitis
C06.405.469.158.188,Colitis,C06.405.469.158.188 - Colitis
D27.505.954.427,Central Nervous System Agents,D27.505.954.427 - Central Nervous System Agents
C05.116.900.853.625.800.744,Axial Spondyloarthritis,C05.116.900.853.625.800.744 - Axial Spondyloarthritis
C05.550.069.340,Axial Spondyloarthritis,C05.550.069.340 - Axial Spondyloarthritis
C05.550.114.865.800.744,Axial Spondyloarthritis,C05.550.114.865.800.744 - Axial Spondyloarthritis
E07.695,Prostheses and Implants,E07.695 - Prostheses and Implants
C14.907.617,Peripheral Vascular Diseases,C14.907.617 - Peripheral Vascular Diseases
C10.803,Restless Legs Syndrome,C10.803 - Restless Legs Syndrome
C10.886.425.800.700,Restless Legs Syndrome,C10.886.425.800.700 - Restless Legs Syndrome
C10.886.659.634,Restless Legs Syndrome,C10.886.659.634 - Restless Legs Syndrome
F03.870.400.800.700,Restless Legs Syndrome,F03.870.400.800.700 - Restless Legs Syndrome
F03.870.664.634,Restless Legs Syndrome,F03.870.664.634 - Restless Legs Syndrome
D12.776.624,Neoplasm Proteins,D12.776.624 - Neoplasm Proteins
D09.947.875.359.448,Glucose,D09.947.875.359.448 - Glucose
D27.505.954.483,Gastrointestinal Agents,D27.505.954.483 - Gastrointestinal Agents
C17.800.685,Pruritus,C17.800.685 - Pruritus
C23.888.885.625,Pruritus,C23.888.885.625 - Pruritus
C11.525,Ocular Hypertension,C11.525 - Ocular Hypertension
D12.776.631,Nerve Tissue Proteins,D12.776.631 - Nerve Tissue Proteins
D27.505.954.502,Hematologic Agents,D27.505.954.502 - Hematologic Agents
F01.145,Behavior,F01.145 - Behavior
C15.378.071,Anemia,C15.378.071 - Anemia
C23.888.942.343,Lower Urinary Tract Symptoms,C23.888.942.343 - Lower Urinary Tract Symptoms
D27.505.954.557,Lipid Regulating Agents,D27.505.954.557 - Lipid Regulating Agents
G07.203.300.600.875,Seafood,G07.203.300.600.875 - Seafood
J02.500.600.875,Seafood,J02.500.600.875 - Seafood
C11.768,Retinal Diseases,C11.768 - Retinal Diseases
C08.381.495.389.750,Pulmonary Emphysema,C08.381.495.389.750 - Pulmonary Emphysema
C23.550.291.500.875.875,Pulmonary Emphysema,C23.550.291.500.875.875 - Pulmonary Emphysema
D12.776.811,Protein Precursors,D12.776.811 - Protein Precursors
F01.393,Defense Mechanisms,F01.393 - Defense Mechanisms
C15.378.100,Blood Coagulation Disorders,C15.378.100 - Blood Coagulation Disorders
D27.505.954.796,Respiratory System Agents,D27.505.954.796 - Respiratory System Agents
D10.532.091.200.100,Apolipoprotein A-I,D10.532.091.200.100 - Apolipoprotein A-I
D12.776.070.400.200.100,Apolipoprotein A-I,D12.776.070.400.200.100 - Apolipoprotein A-I
D12.776.521.120.200.100,Apolipoprotein A-I,D12.776.521.120.200.100 - Apolipoprotein A-I
D12.776.860,Scleroproteins,D12.776.860 - Scleroproteins
C15.378.463,Hemorrhagic Disorders,C15.378.463 - Hemorrhagic Disorders
C12.050,Female Urogenital Diseases and Pregnancy Complications,C12.050 - Female Urogenital Diseases and Pregnancy Complications
F01.470,Emotions,F01.470 - Emotions
D01.268.549.750,Sodium,D01.268.549.750 - Sodium
D01.268.557.650,Sodium,D01.268.557.650 - Sodium
D01.552.528.850,Sodium,D01.552.528.850 - Sodium
D01.552.547.725,Sodium,D01.552.547.725 - Sodium
F01.752,Personality,F01.752 - Personality
C15.378.553,Leukocyte Disorders,C15.378.553 - Leukocyte Disorders
C12.100,Genital Diseases,C12.100 - Genital Diseases
C12.200,Male Urogenital Diseases,C12.200 - Male Urogenital Diseases
C15.378.925,Thrombophilia,C15.378.925 - Thrombophilia
F02.463,Mental Processes,F02.463 - Mental Processes
D06.472.699.631.692.781.100,Arginine Vasopressin,D06.472.699.631.692.781.100 - Arginine Vasopressin
D12.644.400.900.100,Arginine Vasopressin,D12.644.400.900.100 - Arginine Vasopressin
D12.644.456.925.100,Arginine Vasopressin,D12.644.456.925.100 - Arginine Vasopressin
D12.644.548.691.692.781.100,Arginine Vasopressin,D12.644.548.691.692.781.100 - Arginine Vasopressin
D12.776.631.650.937.100,Arginine Vasopressin,D12.776.631.650.937.100 - Arginine Vasopressin
D23.050.285,"Antigens, Neoplasm","D23.050.285 - Antigens, Neoplasm"
E01.370.350.130,Cardiac Imaging Techniques,E01.370.350.130 - Cardiac Imaging Techniques
D01.268.558.362,Lanthanoid Series Elements,D01.268.558.362 - Lanthanoid Series Elements
D01.552.550.399,Lanthanoid Series Elements,D01.552.550.399 - Lanthanoid Series Elements
C14.240,Cardiovascular Abnormalities,C14.240 - Cardiovascular Abnormalities
C16.131.240,Cardiovascular Abnormalities,C16.131.240 - Cardiovascular Abnormalities
D12.644.456.345.600,Lisinopril,D12.644.456.345.600 - Lisinopril
D23.101.140,"Biomarkers, Tumor","D23.101.140 - Biomarkers, Tumor"
E01.370.370.380.150.700,Stroke Volume,E01.370.370.380.150.700 - Stroke Volume
G09.330.380.124.882,Stroke Volume,G09.330.380.124.882 - Stroke Volume
F02.739,Psychological Theory,F02.739 - Psychological Theory
C06.405.205.697,Gastritis,C06.405.205.697 - Gastritis
C06.405.748.398,Gastritis,C06.405.748.398 - Gastritis
C10.228.140.546.399,"Headache Disorders, Primary","C10.228.140.546.399 - Headache Disorders, Primary"
C06.405.205.731,Inflammatory Bowel Diseases,C06.405.205.731 - Inflammatory Bowel Diseases
C06.405.469.432,Inflammatory Bowel Diseases,C06.405.469.432 - Inflammatory Bowel Diseases
E01.370.350.700,Radiography,E01.370.350.700 - Radiography
F02.830,Psychophysiology,F02.830 - Psychophysiology
F04.096.795,Psychophysiology,F04.096.795 - Psychophysiology
H01.158.782.795,Psychophysiology,H01.158.782.795 - Psychophysiology
F03.615,Neurocognitive Disorders,F03.615 - Neurocognitive Disorders
E01.370.350.850,Ultrasonography,E01.370.350.850 - Ultrasonography
C06.405.469.158,Colonic Diseases,C06.405.469.158 - Colonic Diseases
C17.300.200,Collagen Diseases,C17.300.200 - Collagen Diseases
D27.505.519,Molecular Mechanisms of Pharmacological Action,D27.505.519 - Molecular Mechanisms of Pharmacological Action
F03.835,"Sexual Dysfunctions, Psychological","F03.835 - Sexual Dysfunctions, Psychological"
C10.597.606.150.500,Language Disorders,C10.597.606.150.500 - Language Disorders
C23.888.592.604.150.500,Language Disorders,C23.888.592.604.150.500 - Language Disorders
D27.505.696,Physiological Effects of Drugs,D27.505.696 - Physiological Effects of Drugs
C10.597.606.358.800,Unconsciousness,C10.597.606.358.800 - Unconsciousness
C23.888.592.604.359.800,Unconsciousness,C23.888.592.604.359.800 - Unconsciousness
F04.711,Psychological Tests,F04.711 - Psychological Tests
E01.370.370.140,Blood Pressure Determination,E01.370.370.140 - Blood Pressure Determination
E01.370.600.100,Blood Pressure Determination,E01.370.600.100 - Blood Pressure Determination
C08.381.423.847,Pulmonary Arterial Hypertension,C08.381.423.847 - Pulmonary Arterial Hypertension
D27.505.954,Therapeutic Uses,D27.505.954 - Therapeutic Uses
C11.768.585.439.245,Macular Edema,C11.768.585.439.245 - Macular Edema
C14.280,Heart Diseases,C14.280 - Heart Diseases
G03.143,Biological Transport,G03.143 - Biological Transport
C17.800.859,"Skin Diseases, Papulosquamous","C17.800.859 - Skin Diseases, Papulosquamous"
C14.907,Vascular Diseases,C14.907 - Vascular Diseases
D02.455.426.559,"Hydrocarbons, Aromatic","D02.455.426.559 - Hydrocarbons, Aromatic"
E01.370.370.380,Heart Function Tests,E01.370.370.380 - Heart Function Tests
G05.346,Genetic Background,G05.346 - Genetic Background
C17.800.862,"Skin Diseases, Vascular","C17.800.862 - Skin Diseases, Vascular"
E05.318.740.600.800.725,Risk Factors,E05.318.740.600.800.725 - Risk Factors
N05.715.350.200.700,Risk Factors,N05.715.350.200.700 - Risk Factors
N05.715.360.750.625.700.700,Risk Factors,N05.715.360.750.625.700.700 - Risk Factors
N06.850.490.625.750,Risk Factors,N06.850.490.625.750 - Risk Factors
N06.850.520.830.600.800.725,Risk Factors,N06.850.520.830.600.800.725 - Risk Factors
G05.695,Phenotype,G05.695 - Phenotype
D02.455.526.728,Mustard Compounds,D02.455.526.728 - Mustard Compounds
C15.378,Hematologic Diseases,C15.378 - Hematologic Diseases
E01.370.350,Diagnostic Imaging,E01.370.350 - Diagnostic Imaging
E01.370.386.700,Respiratory Function Tests,E01.370.386.700 - Respiratory Function Tests
D12.776.124.400.405,Hemoglobin A,D12.776.124.400.405 - Hemoglobin A
D12.776.422.316.762.380,Hemoglobin A,D12.776.422.316.762.380 - Hemoglobin A
D02.705.429.500,Diphosphonates,D02.705.429.500 - Diphosphonates
E01.370.370,"Diagnostic Techniques, Cardiovascular","E01.370.370 - Diagnostic Techniques, Cardiovascular"
E01.370.600.115,Body Constitution,E01.370.600.115 - Body Constitution
G07.100,Body Constitution,G07.100 - Body Constitution
C16.131,Congenital Abnormalities,C16.131 - Congenital Abnormalities
C12.100.500.565.500,Prostatic Hyperplasia,C12.100.500.565.500 - Prostatic Hyperplasia
C12.200.294.565.500,Prostatic Hyperplasia,C12.200.294.565.500 - Prostatic Hyperplasia
D02.455.526.728.650.730,Phosphoramide Mustards,D02.455.526.728.650.730 - Phosphoramide Mustards
D02.705.672.500,Phosphoramide Mustards,D02.705.672.500 - Phosphoramide Mustards
C16.614,"Infant, Newborn, Diseases","C16.614 - Infant, Newborn, Diseases"
E01.370.374,"Diagnostic Techniques, Endocrine","E01.370.374 - Diagnostic Techniques, Endocrine"
C18.452.174,Calcium Metabolism Disorders,C18.452.174 - Calcium Metabolism Disorders
G07.203,"Diet, Food, and Nutrition","G07.203 - Diet, Food, and Nutrition"
G07.345,Growth and Development,G07.345 - Growth and Development
C18.452.394,Glucose Metabolism Disorders,C18.452.394 - Glucose Metabolism Disorders
E01.370.390.400,Kidney Function Tests,E01.370.390.400 - Kidney Function Tests
D12.776.124.486.485,Immunoglobulins,D12.776.124.486.485 - Immunoglobulins
D12.776.124.790.651,Immunoglobulins,D12.776.124.790.651 - Immunoglobulins
D12.776.377.715.548,Immunoglobulins,D12.776.377.715.548 - Immunoglobulins
E01.370.386,"Diagnostic Techniques, Respiratory System","E01.370.386 - Diagnostic Techniques, Respiratory System"
C17.300,Connective Tissue Diseases,C17.300 - Connective Tissue Diseases
C18.452.584,Lipid Metabolism Disorders,C18.452.584 - Lipid Metabolism Disorders
C17.800,Skin Diseases,C17.800 - Skin Diseases
I01.240.425,Health Status,I01.240.425 - Health Status
N01.224.425,Health Status,N01.224.425 - Health Status
N06.850.505.400.425,Health Status,N06.850.505.400.425 - Health Status
E01.370.388,"Diagnostic Techniques, Surgical","E01.370.388 - Diagnostic Techniques, Surgical"
G07.690,Pharmacological and Toxicological Phenomena,G07.690 - Pharmacological and Toxicological Phenomena
C10.228.140.079,Basal Ganglia Diseases,C10.228.140.079 - Basal Ganglia Diseases
G08.686,Reproductive Physiological Phenomena,G08.686 - Reproductive Physiological Phenomena
C18.452.394.968.500.570,Metabolic Syndrome,C18.452.394.968.500.570 - Metabolic Syndrome
C18.452.625,Metabolic Syndrome,C18.452.625 - Metabolic Syndrome
E01.370.520.200,Drug Monitoring,E01.370.520.200 - Drug Monitoring
C18.452,Metabolic Diseases,C18.452 - Metabolic Diseases
E01.370.390,"Diagnostic Techniques, Urological","E01.370.390 - Diagnostic Techniques, Urological"
C18.452.950,Water-Electrolyte Imbalance,C18.452.950 - Water-Electrolyte Imbalance
G08.852,Urinary Tract Physiological Phenomena,G08.852 - Urinary Tract Physiological Phenomena
C18.654,Nutrition Disorders,C18.654 - Nutrition Disorders
E01.370.405,Electrodiagnosis,E01.370.405 - Electrodiagnosis
E01.370.510,Medical History Taking,E01.370.510 - Medical History Taking
C18.654.422,Infant Nutrition Disorders,C18.654.422 - Infant Nutrition Disorders
C10.228.140.490,Epilepsy,C10.228.140.490 - Epilepsy
G09.188,Blood Physiological Phenomena,G09.188 - Blood Physiological Phenomena
E01.370.600.875,Vital Signs,E01.370.600.875 - Vital Signs
C18.654.521,Malnutrition,C18.654.521 - Malnutrition
C10.228.140.546,Headache Disorders,C10.228.140.546 - Headache Disorders
D03.132.960.877,Uric Acid,D03.132.960.877 - Uric Acid
D03.633.100.759.758.824.877,Uric Acid,D03.633.100.759.758.824.877 - Uric Acid
E01.370.520,"Monitoring, Physiologic","E01.370.520 - Monitoring, Physiologic"
G09.330,Cardiovascular Physiological Phenomena,G09.330 - Cardiovascular Physiological Phenomena
C20.111,Autoimmune Diseases,C20.111 - Autoimmune Diseases
C10.574.945,Tauopathies,C10.574.945 - Tauopathies
D12.776.624.664,Oncogene Proteins,D12.776.624.664 - Oncogene Proteins
D12.644,Peptides,D12.644 - Peptides
C18.452.394.984,Hypoglycemia,C18.452.394.984 - Hypoglycemia
D08.811.277,Hydrolases,D08.811.277 - Hydrolases
C18.452.584.500,Dyslipidemias,C18.452.584.500 - Dyslipidemias
D12.776,Proteins,D12.776 - Proteins
D08.811.520,Lyases,D08.811.520 - Lyases
E02.319.267.082.500,"Infusions, Intravenous","E02.319.267.082.500 - Infusions, Intravenous"
E02.319.267.510.590,"Infusions, Intravenous","E02.319.267.510.590 - Infusions, Intravenous"
D08.811.913,Transferases,D08.811.913 - Transferases
C11.270.612,Retinal Degeneration,C11.270.612 - Retinal Degeneration
C11.768.585,Retinal Degeneration,C11.768.585 - Retinal Degeneration
N02.278.306.472,Hospital Bed Capacity,N02.278.306.472 - Hospital Bed Capacity
K01.400.552,History of Medicine,K01.400.552 - History of Medicine
D23.050,Antigens,D23.050 - Antigens
